| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | I-SMAD binding | 2.69e-06 | 17 | 119 | 4 | GO:0070411 | |
| GeneOntologyMolecularFunction | DEAD/H-box RNA helicase binding | 1.69e-05 | 9 | 119 | 3 | GO:0017151 | |
| GeneOntologyMolecularFunction | co-SMAD binding | 4.37e-05 | 12 | 119 | 3 | GO:0070410 | |
| GeneOntologyMolecularFunction | aspartic-type endopeptidase activity | 6.80e-05 | 37 | 119 | 4 | GO:0004190 | |
| GeneOntologyMolecularFunction | aspartic-type peptidase activity | 7.57e-05 | 38 | 119 | 4 | GO:0070001 | |
| GeneOntologyMolecularFunction | beta-catenin binding | 8.29e-05 | 120 | 119 | 6 | GO:0008013 | |
| GeneOntologyMolecularFunction | nitric-oxide synthase activity | 1.05e-04 | 3 | 119 | 2 | GO:0004517 | |
| GeneOntologyMolecularFunction | SMAD binding | 1.64e-04 | 86 | 119 | 5 | GO:0046332 | |
| GeneOntologyMolecularFunction | tetrahydrobiopterin binding | 2.10e-04 | 4 | 119 | 2 | GO:0034617 | |
| GeneOntologyMolecularFunction | peptide N-acetyltransferase activity | 4.52e-04 | 60 | 119 | 4 | GO:0034212 | |
| GeneOntologyMolecularFunction | phosphatidylinositol binding | 6.18e-04 | 316 | 119 | 8 | GO:0035091 | |
| GeneOntologyMolecularFunction | ubiquitin protein ligase binding | 9.37e-04 | 337 | 119 | 8 | GO:0031625 | |
| GeneOntologyMolecularFunction | N-acetyltransferase activity | 1.22e-03 | 78 | 119 | 4 | GO:0008080 | |
| GeneOntologyMolecularFunction | arginine binding | 1.23e-03 | 9 | 119 | 2 | GO:0034618 | |
| GeneOntologyMolecularFunction | ubiquitin-like protein ligase binding | 1.38e-03 | 358 | 119 | 8 | GO:0044389 | |
| GeneOntologyMolecularFunction | transcription regulator activator activity | 1.54e-03 | 10 | 119 | 2 | GO:0140537 | |
| GeneOntologyMolecularFunction | histone H4K8 acetyltransferase activity | 1.87e-03 | 11 | 119 | 2 | GO:0043996 | |
| GeneOntologyMolecularFunction | histone H4K5 acetyltransferase activity | 1.87e-03 | 11 | 119 | 2 | GO:0043995 | |
| GeneOntologyMolecularFunction | DNA-binding transcription activator activity, RNA polymerase II-specific | HIF1A GBX2 FOSL1 KMT2D NR1I3 NOTCH2 SMAD1 SMAD2 SMAD3 ZNF292 | 1.92e-03 | 560 | 119 | 10 | GO:0001228 |
| GeneOntologyMolecularFunction | DNA-binding transcription activator activity | HIF1A GBX2 FOSL1 KMT2D NR1I3 NOTCH2 SMAD1 SMAD2 SMAD3 ZNF292 | 2.08e-03 | 566 | 119 | 10 | GO:0001216 |
| GeneOntologyMolecularFunction | histone H4K12 acetyltransferase activity | 2.24e-03 | 12 | 119 | 2 | GO:0043997 | |
| GeneOntologyMolecularFunction | cadmium ion binding | 2.24e-03 | 12 | 119 | 2 | GO:0046870 | |
| GeneOntologyMolecularFunction | histone modifying activity | 2.52e-03 | 229 | 119 | 6 | GO:0140993 | |
| GeneOntologyBiologicalProcess | miRNA metabolic process | 6.19e-06 | 119 | 120 | 7 | GO:0010586 | |
| GeneOntologyBiologicalProcess | regulation of miRNA transcription | 8.96e-06 | 83 | 120 | 6 | GO:1902893 | |
| GeneOntologyBiologicalProcess | miRNA transcription | 9.60e-06 | 84 | 120 | 6 | GO:0061614 | |
| GeneOntologyBiologicalProcess | embryo development | HIF1A TCF7 SOBP POLE GBX2 PDZD7 FOSL1 DNAAF2 NCOR2 KMT2D SALL1 BRD2 TJP1 BRPF1 DLG1 NOS3 TCF7L1 NOTCH2 SMAD1 SMAD2 SMAD3 SMAD5 | 2.55e-05 | 1437 | 120 | 22 | GO:0009790 |
| GeneOntologyBiologicalProcess | positive regulation of miRNA transcription | 2.81e-05 | 61 | 120 | 5 | GO:1902895 | |
| GeneOntologyBiologicalProcess | regulation of miRNA metabolic process | 3.09e-05 | 103 | 120 | 6 | GO:2000628 | |
| GeneOntologyBiologicalProcess | ureteric bud development | 3.83e-05 | 107 | 120 | 6 | GO:0001657 | |
| GeneOntologyBiologicalProcess | mesonephric tubule development | 4.47e-05 | 110 | 120 | 6 | GO:0072164 | |
| GeneOntologyBiologicalProcess | mesonephric epithelium development | 4.47e-05 | 110 | 120 | 6 | GO:0072163 | |
| GeneOntologyBiologicalProcess | kidney epithelium development | 4.58e-05 | 162 | 120 | 7 | GO:0072073 | |
| GeneOntologyBiologicalProcess | positive regulation of cell migration | SEMA6C VIL1 LGMN ARHGAP32 HIF1A NTRK3 RAPGEF4 RAB11A RRAS FZD4 TJP1 CD274 NOS3 SMAD3 | 4.97e-05 | 691 | 120 | 14 | GO:0030335 |
| GeneOntologyBiologicalProcess | mesonephros development | 5.20e-05 | 113 | 120 | 6 | GO:0001823 | |
| GeneOntologyBiologicalProcess | positive regulation of miRNA metabolic process | 6.71e-05 | 73 | 120 | 5 | GO:2000630 | |
| GeneOntologyBiologicalProcess | chordate embryonic development | HIF1A TCF7 GBX2 FOSL1 DNAAF2 NCOR2 KMT2D SALL1 BRD2 TJP1 BRPF1 DLG1 NOS3 NOTCH2 SMAD2 SMAD3 | 7.22e-05 | 906 | 120 | 16 | GO:0043009 |
| GeneOntologyBiologicalProcess | negative regulation of muscle adaptation | 8.30e-05 | 15 | 120 | 3 | GO:0014745 | |
| GeneOntologyBiologicalProcess | positive regulation of cell motility | SEMA6C VIL1 LGMN ARHGAP32 HIF1A NTRK3 RAPGEF4 RAB11A RRAS FZD4 TJP1 CD274 NOS3 SMAD3 | 8.30e-05 | 725 | 120 | 14 | GO:2000147 |
| GeneOntologyBiologicalProcess | tube morphogenesis | FOXM1 HIF1A TCF7 GBX2 RRAS FZD4 SALL1 BRD2 TJP1 BRPF1 PAXIP1 DLG1 NOS3 NOTCH2 SMAD1 SMAD2 SMAD3 SMAD5 | 8.78e-05 | 1125 | 120 | 18 | GO:0035239 |
| GeneOntologyBiologicalProcess | embryo development ending in birth or egg hatching | HIF1A TCF7 GBX2 FOSL1 DNAAF2 NCOR2 KMT2D SALL1 BRD2 TJP1 BRPF1 DLG1 NOS3 NOTCH2 SMAD2 SMAD3 | 9.67e-05 | 929 | 120 | 16 | GO:0009792 |
| GeneOntologyBiologicalProcess | Ras protein signal transduction | 1.04e-04 | 128 | 120 | 6 | GO:0007265 | |
| GeneOntologyBiologicalProcess | positive regulation of locomotion | SEMA6C VIL1 LGMN ARHGAP32 HIF1A NTRK3 RAPGEF4 RAB11A RRAS FZD4 TJP1 CD274 NOS3 SMAD3 | 1.06e-04 | 742 | 120 | 14 | GO:0040017 |
| GeneOntologyBiologicalProcess | cellular response to growth factor stimulus | VIL1 LGMN HIF1A MAP1B NTRK3 FZD4 ZFYVE9 DLG1 NOS1 NOS3 NOTCH2 SMAD1 SMAD2 SMAD3 SMAD5 | 1.25e-04 | 850 | 120 | 15 | GO:0071363 |
| GeneOntologyBiologicalProcess | positive regulation of transcription by RNA polymerase II | FOXM1 HIF1A PPRC1 AKNA GBX2 FOSL1 KMT2D MLIP SALL1 MDC1 PAXIP1 NOS1 TCF7L1 NR1I3 NOTCH2 SMAD1 SMAD2 SMAD3 SMAD5 ZNF292 | 1.46e-04 | 1390 | 120 | 20 | GO:0045944 |
| GeneOntologyBiologicalProcess | positive regulation of cellular component biogenesis | VIL1 HIF1A MAP1B NTRK3 CKAP5 SNX30 G3BP1 SNX7 ATF7IP DLG1 ARAP1 SMAD3 | 1.50e-04 | 582 | 120 | 12 | GO:0044089 |
| GeneOntologyBiologicalProcess | tube development | FOXM1 HIF1A TCF7 GBX2 RRAS JMJD1C FZD4 NCOR2 SALL1 BRD2 TJP1 BRPF1 PAXIP1 DLG1 NOS3 NOTCH2 SMAD1 SMAD2 SMAD3 SMAD5 | 1.64e-04 | 1402 | 120 | 20 | GO:0035295 |
| GeneOntologyBiologicalProcess | response to growth factor | VIL1 LGMN HIF1A MAP1B NTRK3 FZD4 ZFYVE9 DLG1 NOS1 NOS3 NOTCH2 SMAD1 SMAD2 SMAD3 SMAD5 | 1.89e-04 | 883 | 120 | 15 | GO:0070848 |
| GeneOntologyBiologicalProcess | embryonic pattern specification | 1.91e-04 | 91 | 120 | 5 | GO:0009880 | |
| GeneOntologyBiologicalProcess | positive regulation of macroautophagy | 2.01e-04 | 92 | 120 | 5 | GO:0016239 | |
| GeneOntologyBiologicalProcess | pulmonary valve morphogenesis | 2.04e-04 | 20 | 120 | 3 | GO:0003184 | |
| GeneOntologyBiologicalProcess | primary miRNA processing | 2.04e-04 | 20 | 120 | 3 | GO:0031053 | |
| GeneOntologyBiologicalProcess | embryonic organ morphogenesis | 2.15e-04 | 351 | 120 | 9 | GO:0048562 | |
| GeneOntologyBiologicalProcess | embryonic morphogenesis | HIF1A TCF7 SOBP GBX2 PDZD7 SALL1 BRD2 BRPF1 DLG1 NOTCH2 SMAD1 SMAD2 SMAD3 | 2.64e-04 | 713 | 120 | 13 | GO:0048598 |
| GeneOntologyBiologicalProcess | epithelium development | HIF1A TCF7 MAP1B NTRK3 GBX2 PDZD7 JMJD1C FZD4 NCOR2 SALL1 BRD2 ALMS1 TJP1 BRPF1 DLG1 NOTCH2 SMAD1 SMAD2 SMAD3 SMAD5 | 3.04e-04 | 1469 | 120 | 20 | GO:0060429 |
| GeneOntologyBiologicalProcess | establishment or maintenance of microtubule cytoskeleton polarity | 3.32e-04 | 5 | 120 | 2 | GO:0030951 | |
| GeneOntologyBiologicalProcess | negative regulation of autophagosome maturation | 3.32e-04 | 5 | 120 | 2 | GO:1901097 | |
| GeneOntologyBiologicalProcess | pulmonary valve development | 3.56e-04 | 24 | 120 | 3 | GO:0003177 | |
| GeneOntologyBiologicalProcess | digestive tract morphogenesis | 3.87e-04 | 59 | 120 | 4 | GO:0048546 | |
| GeneOntologyBiologicalProcess | tissue morphogenesis | HIF1A GBX2 SALL1 BRD2 ALMS1 BRPF1 DLG1 NOS3 TCF7L1 NOTCH2 SMAD1 SMAD2 SMAD3 | 4.28e-04 | 750 | 120 | 13 | GO:0048729 |
| GeneOntologyBiologicalProcess | neural precursor cell proliferation | 4.33e-04 | 233 | 120 | 7 | GO:0061351 | |
| GeneOntologyBiologicalProcess | embryonic organ development | HIF1A TCF7 SOBP POLE GBX2 PDZD7 SALL1 DLG1 NOTCH2 SMAD2 SMAD3 | 4.37e-04 | 561 | 120 | 11 | GO:0048568 |
| GeneOntologyBiologicalProcess | positive regulation of guanylate cyclase activity | 4.96e-04 | 6 | 120 | 2 | GO:0031284 | |
| GeneOntologyBiologicalProcess | osteoblast fate commitment | 4.96e-04 | 6 | 120 | 2 | GO:0002051 | |
| GeneOntologyBiologicalProcess | positive regulation of organelle organization | VIL1 HIF1A MAP1B CKAP5 SNX30 G3BP1 SNX7 ATF7IP DLG1 CLEC16A SMAD3 | 5.29e-04 | 574 | 120 | 11 | GO:0010638 |
| GeneOntologyBiologicalProcess | vasculogenesis | 6.35e-04 | 118 | 120 | 5 | GO:0001570 | |
| GeneOntologyBiologicalProcess | establishment of mitochondrion localization, microtubule-mediated | 6.95e-04 | 30 | 120 | 3 | GO:0034643 | |
| GeneOntologyBiologicalProcess | mitochondrion transport along microtubule | 6.95e-04 | 30 | 120 | 3 | GO:0047497 | |
| GeneOntologyBiologicalProcess | regulation of organelle organization | VIL1 HIF1A MAP1B MAP6 RAB11A CKAP5 SNX30 ALMS1 G3BP1 TJP1 SNX7 ATF7IP DLG1 CLEC16A RUBCN ARAP1 SMAD3 WDR44 | 7.48e-04 | 1342 | 120 | 18 | GO:0033043 |
| GeneOntologyBiologicalProcess | negative regulation of miRNA transcription | 7.66e-04 | 31 | 120 | 3 | GO:1902894 | |
| GeneOntologyBiologicalProcess | regulation of actin filament bundle assembly | 7.67e-04 | 123 | 120 | 5 | GO:0032231 | |
| GeneOntologyBiologicalProcess | regulation of macroautophagy | 7.74e-04 | 186 | 120 | 6 | GO:0016241 | |
| GeneOntologyBiologicalProcess | developmental growth | SEMA6C VIL1 LGMN ARHGAP32 MAP1B NTRK3 KMT2D SALL1 ALMS1 DLG1 NOTCH2 SMAD1 SMAD2 SMAD3 | 8.42e-04 | 911 | 120 | 14 | GO:0048589 |
| GeneOntologyBiologicalProcess | stress fiber assembly | 8.86e-04 | 127 | 120 | 5 | GO:0043149 | |
| GeneOntologyBiologicalProcess | contractile actin filament bundle assembly | 8.86e-04 | 127 | 120 | 5 | GO:0030038 | |
| GeneOntologyBiologicalProcess | actin filament bundle assembly | 8.89e-04 | 191 | 120 | 6 | GO:0051017 | |
| GeneOntologyBiologicalProcess | anatomical structure formation involved in morphogenesis | HIF1A CKAP5 GBX2 ERVK-21 ERVK-9 RRAS SOCS7 FZD4 SALL1 BRD2 TJP1 BRPF1 NOS1 NOS3 NOTCH2 SMAD1 SMAD2 SMAD3 SMAD5 | 9.15e-04 | 1483 | 120 | 19 | GO:0048646 |
| GeneOntologyBiologicalProcess | regulation of transforming growth factor beta2 production | 9.19e-04 | 8 | 120 | 2 | GO:0032909 | |
| GeneOntologyBiologicalProcess | transforming growth factor beta2 production | 9.19e-04 | 8 | 120 | 2 | GO:0032906 | |
| GeneOntologyBiologicalProcess | positive regulation of stress granule assembly | 9.19e-04 | 8 | 120 | 2 | GO:0062029 | |
| GeneOntologyBiologicalProcess | regulation of guanylate cyclase activity | 9.19e-04 | 8 | 120 | 2 | GO:0031282 | |
| GeneOntologyBiologicalProcess | positive regulation of sprouting angiogenesis | 9.22e-04 | 33 | 120 | 3 | GO:1903672 | |
| GeneOntologyBiologicalProcess | actin filament bundle organization | 9.89e-04 | 195 | 120 | 6 | GO:0061572 | |
| GeneOntologyBiologicalProcess | negative regulation of miRNA metabolic process | 1.01e-03 | 34 | 120 | 3 | GO:2000629 | |
| GeneOntologyBiologicalProcess | pattern specification process | HIF1A GBX2 DNAAF2 TCF7L1 CRAMP1 NOTCH2 SMAD1 SMAD2 SMAD3 SMAD5 | 1.01e-03 | 526 | 120 | 10 | GO:0007389 |
| GeneOntologyBiologicalProcess | regulation of nervous system development | SEMA6C ARHGAP32 HIF1A MAP1B MAP6 NTRK3 GBX2 FZD4 DLG1 NOS1 NOTCH2 | 1.06e-03 | 625 | 120 | 11 | GO:0051960 |
| GeneOntologyBiologicalProcess | establishment or maintenance of cytoskeleton polarity | 1.18e-03 | 9 | 120 | 2 | GO:0030952 | |
| GeneOntologyBiologicalProcess | negative regulation of cardiac muscle hypertrophy in response to stress | 1.18e-03 | 9 | 120 | 2 | GO:1903243 | |
| GeneOntologyBiologicalProcess | positive regulation of epithelial cell migration | 1.19e-03 | 202 | 120 | 6 | GO:0010634 | |
| GeneOntologyBiologicalProcess | neural tube development | 1.19e-03 | 202 | 120 | 6 | GO:0021915 | |
| GeneOntologyBiologicalProcess | small GTPase-mediated signal transduction | FOXM1 ARHGAP32 KSR2 RAPGEF4 RRAS G3BP1 DENND4B ARHGAP27 NOTCH2 ARAP1 | 1.20e-03 | 538 | 120 | 10 | GO:0007264 |
| GeneOntologyBiologicalProcess | negative regulation of DNA-templated transcription | FOXM1 HIF1A TCF7 ETV7 SFMBT2 NSD3 NCOR2 ZNF469 MLIP SALL1 ATF7IP DLG1 TCF7L1 NR1I3 NOTCH2 SMAD2 SMAD3 SMAD5 | 1.20e-03 | 1399 | 120 | 18 | GO:0045892 |
| GeneOntologyCellularComponent | heteromeric SMAD protein complex | 7.34e-08 | 8 | 121 | 4 | GO:0071144 | |
| GeneOntologyCellularComponent | SMAD protein complex | 2.18e-07 | 10 | 121 | 4 | GO:0071141 | |
| GeneOntologyCellularComponent | homomeric SMAD protein complex | 3.32e-05 | 2 | 121 | 2 | GO:0071142 | |
| GeneOntologyCellularComponent | chromatin | FOXM1 BRPF3 HIF1A TCF7 ETV7 FAM47C GBX2 SRCAP JMJD1C NSD3 FOSL1 NCOR2 SALL1 BRD2 BRPF1 SHPRH TCF7L1 NR1I3 SMAD1 SMAD2 SMAD3 SMAD5 | 3.72e-05 | 1480 | 121 | 22 | GO:0000785 |
| GeneOntologyCellularComponent | nuclear protein-containing complex | HIF1A TCF7 PNN POLE DDX42 NUP214 SRCAP JMJD1C FOSL1 EFTUD2 NCOR2 KMT2D SALL1 PAXIP1 ACIN1 TCF7L1 SMAD1 SMAD2 SMAD3 SMAD5 | 1.21e-04 | 1377 | 121 | 20 | GO:0140513 |
| GeneOntologyCellularComponent | main axon | 1.68e-04 | 89 | 121 | 5 | GO:0044304 | |
| GeneOntologyCellularComponent | RNA polymerase II transcription regulator complex | 1.88e-04 | 272 | 121 | 8 | GO:0090575 | |
| GeneOntologyCellularComponent | MOZ/MORF histone acetyltransferase complex | 6.85e-04 | 7 | 121 | 2 | GO:0070776 | |
| GeneOntologyCellularComponent | transcription regulator complex | HIF1A TCF7 FOSL1 NCOR2 SALL1 ATF7IP TCF7L1 SMAD1 SMAD2 SMAD3 SMAD5 | 6.94e-04 | 596 | 121 | 11 | GO:0005667 |
| GeneOntologyCellularComponent | nuclear body | HIF1A TCF7 PNN DDX42 SRCAP SFMBT2 EFTUD2 NCOR2 MLIP BRD2 ATF7IP MDC1 LRCH4 ACIN1 | 7.38e-04 | 903 | 121 | 14 | GO:0016604 |
| GeneOntologyCellularComponent | H3 histone acetyltransferase complex | 9.09e-04 | 8 | 121 | 2 | GO:0070775 | |
| GeneOntologyCellularComponent | microtubule | 1.08e-03 | 533 | 121 | 10 | GO:0005874 | |
| GeneOntologyCellularComponent | histone deacetylase complex | 1.51e-03 | 85 | 121 | 4 | GO:0000118 | |
| MousePheno | abnormal embryonic growth/weight/body size | HIF1A DIS3L2 PNN TRPM7 RAB11A CKAP5 SFMBT2 FOSL1 EFTUD2 DNAAF2 NCOR2 BRD2 G3BP1 TJP1 PAXIP1 DLG1 CLEC16A TCF7L1 CRAMP1 NOTCH2 SMAD1 SMAD2 SMAD5 | 6.25e-06 | 1295 | 91 | 23 | MP:0002088 |
| MousePheno | abnormal developmental patterning | HIF1A PNN PPRC1 RAB11A CKAP5 SFMBT2 DNAAF2 G3BP1 TJP1 PAXIP1 TCF7L1 SMAD1 SMAD2 SMAD5 | 2.02e-05 | 577 | 91 | 14 | MP:0002084 |
| MousePheno | abnormal prenatal growth/weight/body size | HIF1A DIS3L2 PNN TRPM7 RAB11A CKAP5 SFMBT2 FOSL1 EFTUD2 DNAAF2 NCOR2 BRD2 G3BP1 TJP1 PAXIP1 DLG1 CLEC16A NOS3 TCF7L1 CRAMP1 NOTCH2 SMAD1 SMAD2 SMAD5 | 2.03e-05 | 1493 | 91 | 24 | MP:0004196 |
| MousePheno | abnormal kidney apoptosis | 2.35e-05 | 53 | 91 | 5 | MP:0011367 | |
| MousePheno | abnormal cerebral blood flow rate | 4.19e-05 | 2 | 91 | 2 | MP:0031182 | |
| MousePheno | embryonic lethality during organogenesis, complete penetrance | HIF1A PNN DDX42 FOSL1 DNAAF2 KMT2D BRD2 TJP1 BRPF1 PAXIP1 TCF7L1 NOTCH2 SMAD1 SMAD2 SMAD5 | 4.23e-05 | 700 | 91 | 15 | MP:0011098 |
| MousePheno | abnormal blood vessel morphology | FOXM1 HIF1A NTRK3 GBX2 FRYL RRAS PDHX SOCS7 FOSL1 FZD4 DNAAF2 NCOR2 BRD2 TULP4 TJP1 PAXIP1 THNSL2 NOS1 NOS3 TCF7L1 NOTCH2 SMAD2 SMAD5 | 4.97e-05 | 1472 | 91 | 23 | MP:0001614 |
| MousePheno | abnormal cardiovascular development | FOXM1 HIF1A PNN NTRK3 GBX2 RRAS FOSL1 FZD4 DNAAF2 NCOR2 BRD2 TJP1 PAXIP1 NOS3 SMAD2 SMAD5 | 5.38e-05 | 802 | 91 | 16 | MP:0002925 |
| MousePheno | increased embryonic tissue cell apoptosis | 6.15e-05 | 153 | 91 | 7 | MP:0013504 | |
| MousePheno | abnormal fluid regulation | FOXM1 HIF1A MAP1B PNN SFMBT2 SULT1E1 FZD4 DNAAF2 NCOR2 BRD2 TULP4 NOS1 NOS3 TCF7L1 NOTCH2 SMAD5 | 7.64e-05 | 826 | 91 | 16 | MP:0001784 |
| MousePheno | perinatal lethality | FOXM1 DIS3L2 MAP1B PNN MAP6 NTRK3 GBX2 LCP2 EFTUD2 SALL1 BRD2 G3BP1 TULP4 DLG1 CLEC16A NOS3 TCF7L1 NOTCH2 SMAD2 | 1.00e-04 | 1130 | 91 | 19 | MP:0002081 |
| MousePheno | abnormal digestive system morphology | SEMA6C TCF7 PNN POLE CKAP5 GATM GBX2 ANKRD20A8P FOCAD FZD4 DNAAF2 SALL1 DLG1 NOS1 TCF7L1 CRAMP1 SMAD1 SMAD2 SMAD3 SMAD5 | 1.04e-04 | 1233 | 91 | 20 | MP:0000462 |
| MousePheno | abnormal chorion morphology | 1.18e-04 | 74 | 91 | 5 | MP:0002836 | |
| MousePheno | abnormal brain blood flow rate | 1.25e-04 | 3 | 91 | 2 | MP:0031179 | |
| MousePheno | abnormal embryo size | HIF1A DIS3L2 TRPM7 RAB11A CKAP5 FOSL1 DNAAF2 BRD2 TJP1 PAXIP1 DLG1 CLEC16A TCF7L1 CRAMP1 SMAD1 SMAD2 SMAD5 | 1.27e-04 | 956 | 91 | 17 | MP:0001697 |
| MousePheno | abnormal embryonic tissue physiology | 1.33e-04 | 297 | 91 | 9 | MP:0008932 | |
| MousePheno | abnormal placenta morphology | DDX42 FRYL SFMBT2 FOSL1 FOCAD NCOR2 TJP1 PAXIP1 CRAMP1 NOTCH2 SMAD1 SMAD2 | 1.47e-04 | 525 | 91 | 12 | MP:0001711 |
| MousePheno | abnormal angiogenesis | 1.49e-04 | 372 | 91 | 10 | MP:0000260 | |
| MousePheno | abnormal embryo development | HIF1A PNN TRPM7 PPRC1 RAB11A CKAP5 SRCAP SFMBT2 EFTUD2 DNAAF2 NCOR2 BRD2 G3BP1 TJP1 BRPF1 PAXIP1 TCF7L1 NOTCH2 SMAD1 SMAD2 SMAD5 | 1.51e-04 | 1370 | 91 | 21 | MP:0001672 |
| MousePheno | embryonic lethality during organogenesis | HIF1A PNN DDX42 FOSL1 DNAAF2 KMT2D SALL1 BRD2 TJP1 BRPF1 PAXIP1 TCF7L1 NOTCH2 SMAD1 SMAD2 SMAD5 | 1.52e-04 | 876 | 91 | 16 | MP:0006207 |
| MousePheno | abnormal embryonic tissue cell apoptosis | 1.70e-04 | 180 | 91 | 7 | MP:0013503 | |
| MousePheno | increased kidney apoptosis | 1.71e-04 | 43 | 91 | 4 | MP:0011368 | |
| MousePheno | renal hypoplasia | 1.87e-04 | 44 | 91 | 4 | MP:0003446 | |
| MousePheno | digestive/alimentary phenotype | SEMA6C TCF7 PNN TRPM7 POLE CKAP5 GATM GBX2 ANKRD20A8P FOCAD FZD4 DNAAF2 SALL1 DLG1 NOS1 NOS3 TCF7L1 CRAMP1 SMAD1 SMAD2 SMAD3 SMAD5 | 1.92e-04 | 1500 | 91 | 22 | MP:0005381 |
| MousePheno | abnormal vascular development | HIF1A GBX2 RRAS FOSL1 FZD4 DNAAF2 BRD2 TJP1 PAXIP1 NOS3 SMAD2 SMAD5 | 1.97e-04 | 542 | 91 | 12 | MP:0000259 |
| MousePheno | abnormal rostral-caudal axis patterning | 2.19e-04 | 132 | 91 | 6 | MP:0005221 | |
| MousePheno | abnormal gastrulation | PNN PPRC1 RAB11A CKAP5 SFMBT2 DNAAF2 TJP1 PAXIP1 SMAD1 SMAD2 SMAD5 | 2.27e-04 | 469 | 91 | 11 | MP:0001695 |
| MousePheno | abnormal artery development | 2.28e-04 | 133 | 91 | 6 | MP:0003410 | |
| MousePheno | abnormal extraembryonic tissue morphology | HIF1A DDX42 FRYL SFMBT2 FOSL1 FOCAD DNAAF2 NCOR2 BRD2 TJP1 PAXIP1 CRAMP1 NOTCH2 SMAD1 SMAD2 SMAD5 | 2.29e-04 | 908 | 91 | 16 | MP:0002086 |
| MousePheno | decreased coronary flow rate | 2.49e-04 | 4 | 91 | 2 | MP:0003023 | |
| MousePheno | abnormal hepatic portal vein connection | 2.49e-04 | 4 | 91 | 2 | MP:0013814 | |
| MousePheno | abnormal external carotid artery origin | 2.49e-04 | 4 | 91 | 2 | MP:0013995 | |
| MousePheno | abnormal chorioallantoic fusion | 2.97e-04 | 90 | 91 | 5 | MP:0002824 | |
| MousePheno | decreased embryo size | HIF1A TRPM7 RAB11A FOSL1 DNAAF2 BRD2 TJP1 PAXIP1 DLG1 TCF7L1 SMAD1 SMAD2 SMAD5 | 3.25e-04 | 659 | 91 | 13 | MP:0001698 |
| MousePheno | rostral body truncation | 3.26e-04 | 21 | 91 | 3 | MP:0012157 | |
| MousePheno | renal tubular necrosis | 3.26e-04 | 21 | 91 | 3 | MP:0004154 | |
| MousePheno | abnormal blood circulation | FOXM1 HIF1A DIS3L2 NTRK3 FRYL SOCS7 FZD4 BRD2 G3BP1 MDC1 NOS1 NOS3 TCF7L1 NOTCH2 SMAD5 | 3.40e-04 | 845 | 91 | 15 | MP:0002128 |
| MousePheno | hemorrhage | FOXM1 HIF1A DIS3L2 NTRK3 FRYL SOCS7 FZD4 BRD2 G3BP1 NOS3 TCF7L1 NOTCH2 SMAD5 | 3.50e-04 | 664 | 91 | 13 | MP:0001914 |
| MousePheno | edema | FOXM1 PNN SFMBT2 FZD4 DNAAF2 NCOR2 BRD2 TULP4 NOS3 TCF7L1 NOTCH2 SMAD5 | 3.73e-04 | 581 | 91 | 12 | MP:0001785 |
| MousePheno | abnormal external carotid artery morphology | 4.14e-04 | 5 | 91 | 2 | MP:0012731 | |
| MousePheno | renal interstitial fibrosis | 4.14e-04 | 54 | 91 | 4 | MP:0003215 | |
| MousePheno | abnormal nephron morphology | 4.41e-04 | 426 | 91 | 10 | MP:0003881 | |
| MousePheno | prenatal growth retardation | HIF1A PNN SFMBT2 EFTUD2 DNAAF2 NCOR2 BRD2 G3BP1 TJP1 PAXIP1 DLG1 NOS3 NOTCH2 SMAD2 SMAD5 | 4.57e-04 | 869 | 91 | 15 | MP:0010865 |
| MousePheno | abnormal artery morphology | 5.68e-04 | 440 | 91 | 10 | MP:0002191 | |
| MousePheno | abnormal kidney cell proliferation | 6.23e-04 | 26 | 91 | 3 | MP:0011439 | |
| MousePheno | abnormal renal tubule morphology | 6.91e-04 | 227 | 91 | 7 | MP:0002703 | |
| MousePheno | abnormal prenatal body size | HIF1A DIS3L2 TRPM7 RAB11A CKAP5 FOSL1 DNAAF2 BRD2 TJP1 PAXIP1 DLG1 CLEC16A TCF7L1 CRAMP1 SMAD1 SMAD2 SMAD5 | 7.73e-04 | 1116 | 91 | 17 | MP:0010866 |
| MousePheno | abnormal allantois morphology | 8.12e-04 | 112 | 91 | 5 | MP:0001726 | |
| MousePheno | abnormal adiponectin level | 8.40e-04 | 65 | 91 | 4 | MP:0004891 | |
| MousePheno | abnormal hyaloid artery morphology | 8.62e-04 | 7 | 91 | 2 | MP:0012537 | |
| MousePheno | abnormal kidney interstitium morphology | 9.42e-04 | 67 | 91 | 4 | MP:0011425 | |
| MousePheno | failure of chorioallantoic fusion | 9.42e-04 | 67 | 91 | 4 | MP:0009657 | |
| MousePheno | renal necrosis | 9.54e-04 | 30 | 91 | 3 | MP:0003946 | |
| MousePheno | abnormal foregut morphology | 9.54e-04 | 30 | 91 | 3 | MP:0000474 | |
| MousePheno | disorganized embryonic tissue | 1.05e-03 | 31 | 91 | 3 | MP:0003988 | |
| Domain | DWB | 9.37e-08 | 8 | 115 | 4 | SM00524 | |
| Domain | MH2 | 9.37e-08 | 8 | 115 | 4 | PS51076 | |
| Domain | MH1 | 9.37e-08 | 8 | 115 | 4 | PS51075 | |
| Domain | - | 9.37e-08 | 8 | 115 | 4 | 3.90.520.10 | |
| Domain | MAD_homology_MH1 | 9.37e-08 | 8 | 115 | 4 | IPR013019 | |
| Domain | Dwarfin | 9.37e-08 | 8 | 115 | 4 | IPR013790 | |
| Domain | MH2 | 9.37e-08 | 8 | 115 | 4 | PF03166 | |
| Domain | SMAD_dom_Dwarfin-type | 9.37e-08 | 8 | 115 | 4 | IPR001132 | |
| Domain | MAD_homology1_Dwarfin-type | 6.50e-07 | 12 | 115 | 4 | IPR003619 | |
| Domain | DWA | 6.50e-07 | 12 | 115 | 4 | SM00523 | |
| Domain | MH1 | 6.50e-07 | 12 | 115 | 4 | PF03165 | |
| Domain | SMAD_FHA_domain | 7.72e-07 | 52 | 115 | 6 | IPR008984 | |
| Domain | SMAD_dom-like | 2.34e-06 | 16 | 115 | 4 | IPR017855 | |
| Domain | - | 2.34e-06 | 16 | 115 | 4 | 2.60.200.10 | |
| Domain | NO_synthase | 1.12e-04 | 3 | 115 | 2 | PF02898 | |
| Domain | RTT107_BRCT_5 | 1.12e-04 | 3 | 115 | 2 | PF16770 | |
| Domain | NOS_euk | 1.12e-04 | 3 | 115 | 2 | IPR012144 | |
| Domain | - | 1.12e-04 | 3 | 115 | 2 | 3.90.340.10 | |
| Domain | NOS_N | 1.12e-04 | 3 | 115 | 2 | IPR004030 | |
| Domain | NOS | 1.12e-04 | 3 | 115 | 2 | PS60001 | |
| Domain | PHD | 2.23e-04 | 89 | 115 | 5 | SM00249 | |
| Domain | CTNNB1_binding | 2.24e-04 | 4 | 115 | 2 | PF08347 | |
| Domain | FAM47 | 2.24e-04 | 4 | 115 | 2 | PF14642 | |
| Domain | TCF/LEF | 2.24e-04 | 4 | 115 | 2 | IPR024940 | |
| Domain | CTNNB1-bd_N | 2.24e-04 | 4 | 115 | 2 | IPR013558 | |
| Domain | FAM47 | 2.24e-04 | 4 | 115 | 2 | IPR032743 | |
| Domain | PWWP | 2.40e-04 | 20 | 115 | 3 | SM00293 | |
| Domain | Znf_PHD | 2.47e-04 | 91 | 115 | 5 | IPR001965 | |
| Domain | Znf_FYVE_PHD | 2.99e-04 | 147 | 115 | 6 | IPR011011 | |
| Domain | ZF_PHD_2 | 3.02e-04 | 95 | 115 | 5 | PS50016 | |
| Domain | ZF_PHD_1 | 3.17e-04 | 96 | 115 | 5 | PS01359 | |
| Domain | EPHD | 3.22e-04 | 22 | 115 | 3 | PS51805 | |
| Domain | PWWP | 3.68e-04 | 23 | 115 | 3 | PF00855 | |
| Domain | PWWP_dom | 3.68e-04 | 23 | 115 | 3 | IPR000313 | |
| Domain | PWWP | 4.19e-04 | 24 | 115 | 3 | PS50812 | |
| Domain | Bromodomain_CS | 5.33e-04 | 26 | 115 | 3 | IPR018359 | |
| Domain | FAD_binding_1 | 5.55e-04 | 6 | 115 | 2 | PF00667 | |
| Domain | - | 5.55e-04 | 6 | 115 | 2 | 1.20.990.10 | |
| Domain | FAD-binding_1 | 5.55e-04 | 6 | 115 | 2 | IPR003097 | |
| Domain | NADPH_Cyt_P450_Rdtase_dom3 | 5.55e-04 | 6 | 115 | 2 | IPR023173 | |
| Domain | Zinc_finger_PHD-type_CS | 6.91e-04 | 65 | 115 | 4 | IPR019786 | |
| Domain | Flavodoxin/NO_synth | 1.03e-03 | 8 | 115 | 2 | IPR008254 | |
| Domain | Flavdoxin-like | 1.03e-03 | 8 | 115 | 2 | IPR001094 | |
| Domain | EPL1 | 1.03e-03 | 8 | 115 | 2 | PF10513 | |
| Domain | FLAVODOXIN_LIKE | 1.03e-03 | 8 | 115 | 2 | PS50902 | |
| Domain | Enhancer_polycomb-like_N | 1.03e-03 | 8 | 115 | 2 | IPR019542 | |
| Domain | Flavodoxin_1 | 1.03e-03 | 8 | 115 | 2 | PF00258 | |
| Domain | ZU5 | 1.32e-03 | 9 | 115 | 2 | SM00218 | |
| Domain | Znf_PHD-finger | 1.44e-03 | 79 | 115 | 4 | IPR019787 | |
| Domain | BROMODOMAIN_1 | 1.52e-03 | 37 | 115 | 3 | PS00633 | |
| Domain | - | 1.64e-03 | 10 | 115 | 2 | 3.40.50.360 | |
| Domain | Flavoprotein-like_dom | 1.64e-03 | 10 | 115 | 2 | IPR029039 | |
| Domain | ZU5 | 1.64e-03 | 10 | 115 | 2 | PS51145 | |
| Domain | Flavoprot_Pyr_Nucl_cyt_Rdtase | 1.64e-03 | 10 | 115 | 2 | IPR001709 | |
| Domain | Bromodomain | 1.64e-03 | 38 | 115 | 3 | PF00439 | |
| Domain | BROMODOMAIN_2 | 2.04e-03 | 41 | 115 | 3 | PS50014 | |
| Domain | Bromodomain | 2.19e-03 | 42 | 115 | 3 | IPR001487 | |
| Domain | BROMO | 2.19e-03 | 42 | 115 | 3 | SM00297 | |
| Domain | - | 2.19e-03 | 42 | 115 | 3 | 1.20.920.10 | |
| Domain | OxRdtase_FAD/NAD-bd | 2.38e-03 | 12 | 115 | 2 | IPR001433 | |
| Domain | NAD_binding_1 | 2.38e-03 | 12 | 115 | 2 | PF00175 | |
| Domain | ZU5 | 2.38e-03 | 12 | 115 | 2 | PF00791 | |
| Domain | ZU5_dom | 2.38e-03 | 12 | 115 | 2 | IPR000906 | |
| Domain | uDENN | 3.26e-03 | 14 | 115 | 2 | SM00800 | |
| Domain | PX | 3.41e-03 | 49 | 115 | 3 | PF00787 | |
| Domain | PX | 3.61e-03 | 50 | 115 | 3 | PS50195 | |
| Domain | uDENN | 3.74e-03 | 15 | 115 | 2 | PF03456 | |
| Domain | - | 3.82e-03 | 51 | 115 | 3 | 3.30.1520.10 | |
| Domain | Phox | 4.04e-03 | 52 | 115 | 3 | IPR001683 | |
| Domain | - | 4.18e-03 | 106 | 115 | 4 | 1.10.150.50 | |
| Domain | HMG_box | 4.26e-03 | 53 | 115 | 3 | PF00505 | |
| Domain | Post-SET_dom | 4.26e-03 | 16 | 115 | 2 | IPR003616 | |
| Domain | DENN | 4.26e-03 | 16 | 115 | 2 | SM00799 | |
| Domain | PostSET | 4.26e-03 | 16 | 115 | 2 | SM00508 | |
| Domain | DENN | 4.26e-03 | 16 | 115 | 2 | PF02141 | |
| Domain | dDENN | 4.26e-03 | 16 | 115 | 2 | PF03455 | |
| Domain | UDENN | 4.26e-03 | 16 | 115 | 2 | PS50946 | |
| Domain | DDENN | 4.26e-03 | 16 | 115 | 2 | PS50947 | |
| Domain | dDENN | 4.26e-03 | 16 | 115 | 2 | SM00801 | |
| Domain | dDENN_dom | 4.26e-03 | 16 | 115 | 2 | IPR005112 | |
| Domain | uDENN_dom | 4.26e-03 | 16 | 115 | 2 | IPR005113 | |
| Domain | DENN | 4.26e-03 | 16 | 115 | 2 | PS50211 | |
| Domain | DENN_dom | 4.26e-03 | 16 | 115 | 2 | IPR001194 | |
| Domain | POST_SET | 4.26e-03 | 16 | 115 | 2 | PS50868 | |
| Domain | HMG | 4.49e-03 | 54 | 115 | 3 | SM00398 | |
| Domain | - | 4.73e-03 | 55 | 115 | 3 | 1.10.30.10 | |
| Domain | SAM/pointed | 5.93e-03 | 117 | 115 | 4 | IPR013761 | |
| Domain | Fd_Rdtase_FAD-bd | 6.00e-03 | 19 | 115 | 2 | IPR017927 | |
| Domain | FAD_FR | 6.00e-03 | 19 | 115 | 2 | PS51384 | |
| Domain | BRCT | 6.00e-03 | 19 | 115 | 2 | PF00533 | |
| Domain | Riboflavin_synthase-like_b-brl | 6.00e-03 | 19 | 115 | 2 | IPR017938 | |
| Pathway | WP_NEOVASCULARIZATION_PROCESSES | 2.35e-06 | 37 | 83 | 5 | M39506 | |
| Pathway | REACTOME_LOSS_OF_FUNCTION_OF_SMAD2_3_IN_CANCER | 6.77e-06 | 7 | 83 | 3 | M29623 | |
| Pathway | WP_MECHANISMS_ASSOCIATED_WITH_PLURIPOTENCY | 1.04e-05 | 301 | 83 | 10 | MM15983 | |
| Pathway | REACTOME_SIGNALING_BY_TGF_BETA_RECEPTOR_COMPLEX_IN_CANCER | 1.08e-05 | 8 | 83 | 3 | M27246 | |
| Pathway | WP_TGFBETA_SIGNALING_PATHWAY | 1.44e-05 | 53 | 83 | 5 | MM15880 | |
| Pathway | WP_TGFBETA_RECEPTOR_SIGNALING | 1.73e-05 | 55 | 83 | 5 | M39351 | |
| Pathway | WP_TGFBETA_RECEPTOR_SIGNALING_IN_SKELETAL_DYSPLASIAS | 2.44e-05 | 59 | 83 | 5 | M39886 | |
| Pathway | WP_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_IN_COLORECTAL_CANCER | 4.46e-05 | 161 | 83 | 7 | M39770 | |
| Pathway | REACTOME_SIGNALING_BY_TGFB_FAMILY_MEMBERS | 6.76e-05 | 118 | 83 | 6 | MM15588 | |
| Pathway | REACTOME_FORMATION_OF_AXIAL_MESODERM | 6.84e-05 | 14 | 83 | 3 | M46441 | |
| Pathway | KEGG_ADHERENS_JUNCTION | 6.87e-05 | 73 | 83 | 5 | M638 | |
| Pathway | PID_SMAD2_3PATHWAY | 1.04e-04 | 16 | 83 | 3 | M228 | |
| Pathway | REACTOME_GERM_LAYER_FORMATION_AT_GASTRULATION | 1.26e-04 | 17 | 83 | 3 | M45017 | |
| Pathway | KEGG_TGF_BETA_SIGNALING_PATHWAY | 1.50e-04 | 86 | 83 | 5 | M2642 | |
| Pathway | BIOCARTA_TGFB_PATHWAY | 1.78e-04 | 19 | 83 | 3 | M18933 | |
| Pathway | KEGG_WNT_SIGNALING_PATHWAY | 2.62e-04 | 151 | 83 | 6 | M19428 | |
| Pathway | WP_OVERLAP_BETWEEN_SIGNAL_TRANSDUCTION_PATHWAYS_CONTRIBUTING_TO_LMNA_LAMINOPATHIES | 3.48e-04 | 57 | 83 | 4 | M39877 | |
| Pathway | WP_ANGIOGENESIS | 3.64e-04 | 24 | 83 | 3 | M39556 | |
| Pathway | REACTOME_DOWNREGULATION_OF_SMAD2_3_SMAD4_TRANSCRIPTIONAL_ACTIVITY | 3.64e-04 | 24 | 83 | 3 | MM14877 | |
| Pathway | REACTOME_SIGNALING_BY_TGFB_FAMILY_MEMBERS | 3.69e-04 | 161 | 83 | 6 | M27871 | |
| Pathway | WP_MACROPHAGESTIMULATING_PROTEIN_MSP_SIGNALING | 4.34e-04 | 108 | 83 | 5 | M48078 | |
| Pathway | REACTOME_DOWNREGULATION_OF_TGF_BETA_RECEPTOR_SIGNALING | 4.64e-04 | 26 | 83 | 3 | M628 | |
| Pathway | REACTOME_FORMATION_OF_THE_BETA_CATENIN_TCF_TRANSACTIVATING_COMPLEX | 4.64e-04 | 26 | 83 | 3 | MM14793 | |
| Pathway | WP_WNT_SIGNALING_PATHWAY | 4.73e-04 | 110 | 83 | 5 | MM15977 | |
| Pathway | KEGG_COLORECTAL_CANCER | 4.81e-04 | 62 | 83 | 4 | M14631 | |
| Pathway | REACTOME_RUNX3_REGULATES_WNT_SIGNALING | 5.06e-04 | 6 | 83 | 2 | MM15542 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_SALMONELLA_AVRA_TO_BETA_CATENIN_SIGNALING_PATHWAY | 5.06e-04 | 6 | 83 | 2 | M47736 | |
| Pathway | REACTOME_SIGNALING_BY_NODAL | 5.06e-04 | 6 | 83 | 2 | MM14517 | |
| Pathway | REACTOME_CHROMATIN_MODIFYING_ENZYMES | 5.75e-04 | 175 | 83 | 6 | MM14941 | |
| Pathway | WP_ANGIOTENSIN_II_RECEPTOR_TYPE_1_PATHWAY | 5.80e-04 | 28 | 83 | 3 | M42541 | |
| Pathway | WP_AGERAGE_PATHWAY | 6.10e-04 | 66 | 83 | 4 | M39420 | |
| Pathway | KEGG_MEDICUS_REFERENCE_BMP15_SIGNALING_PATHWAY | 7.06e-04 | 7 | 83 | 2 | M47845 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_KSHV_LANA_TO_WNT_SIGNALING_PATHWAY | 7.06e-04 | 7 | 83 | 2 | M47465 | |
| Pathway | REACTOME_FOXO_MEDIATED_TRANSCRIPTION_OF_CELL_CYCLE_GENES | 7.06e-04 | 7 | 83 | 2 | MM15661 | |
| Pathway | REACTOME_DOWNREGULATION_OF_SMAD2_3_SMAD4_TRANSCRIPTIONAL_ACTIVITY | 7.85e-04 | 31 | 83 | 3 | M669 | |
| Pathway | WP_REGUCALCIN_IN_PROXIMAL_TUBULE_EPITHELIAL_KIDNEY_CELLS | 8.63e-04 | 32 | 83 | 3 | M39893 | |
| Pathway | WP_CHROMOSOMAL_AND_MICROSATELLITE_INSTABILITY_IN_COLORECTAL_CANCER | 8.93e-04 | 73 | 83 | 4 | M39758 | |
| Pathway | REACTOME_REGULATION_OF_MITF_M_DEPENDENT_GENES_INVOLVED_IN_CELL_CYCLE_AND_PROLIFERATION | 9.37e-04 | 8 | 83 | 2 | MM17229 | |
| Pathway | REACTOME_BINDING_OF_TCF_LEF_CTNNB1_TO_TARGET_GENE_PROMOTERS | 9.37e-04 | 8 | 83 | 2 | M27359 | |
| Pathway | KEGG_MEDICUS_VARIANT_CDH1_REDUCED_EXPRESSION_TO_BETA_CATENIN_SIGNALING_PATHWAY | 9.37e-04 | 8 | 83 | 2 | M47413 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TGF_BETA_SIGNALING_PATHWAY | 9.37e-04 | 8 | 83 | 2 | M47415 | |
| Pathway | KEGG_MEDICUS_REFERENCE_NODAL_SIGNALING_PATHWAY | 9.37e-04 | 8 | 83 | 2 | M47849 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ACTIVIN_SIGNALING_PATHWAY | 9.37e-04 | 8 | 83 | 2 | M47846 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MYOSTATIN_SIGNALING_PATHWAY | 9.37e-04 | 8 | 83 | 2 | M47847 | |
| Pathway | REACTOME_RUNX3_REGULATES_WNT_SIGNALING | 9.37e-04 | 8 | 83 | 2 | M27821 | |
| Pathway | WP_EFFECTS_OF_NITRIC_OXIDE | 9.37e-04 | 8 | 83 | 2 | M39677 | |
| Pathway | REACTOME_GASTRULATION | 9.74e-04 | 129 | 83 | 5 | M46433 | |
| Pathway | REACTOME_SIGNALING_BY_TGF_BETA_RECEPTOR_COMPLEX | 1.09e-03 | 77 | 83 | 4 | MM14670 | |
| Pathway | KEGG_MEDICUS_REFERENCE_AMH_SIGNALING_PATHWAY | 1.20e-03 | 9 | 83 | 2 | M47844 | |
| Pathway | KEGG_MEDICUS_REFERENCE_BMP9_10_SIGNALING_PATHWAY | 1.20e-03 | 9 | 83 | 2 | M47822 | |
| Pathway | WP_DELTANOTCH_SIGNALING_PATHWAY | 1.38e-03 | 82 | 83 | 4 | MM15922 | |
| Pathway | REACTOME_TGF_BETA_RECEPTOR_SIGNALING_ACTIVATES_SMADS | 1.43e-03 | 38 | 83 | 3 | MM14874 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_AXIN_TO_WNT_SIGNALING_PATHWAY | 1.49e-03 | 10 | 83 | 2 | M47486 | |
| Pathway | REACTOME_REPRESSION_OF_WNT_TARGET_GENES | 1.49e-03 | 10 | 83 | 2 | MM15156 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_ACTIVITY_OF_SMAD2_SMAD3_SMAD4_HETEROTRIMER | 1.79e-03 | 41 | 83 | 3 | MM14876 | |
| Pathway | PID_ALK2_PATHWAY | 1.82e-03 | 11 | 83 | 2 | M203 | |
| Pathway | REACTOME_STAT3_NUCLEAR_EVENTS_DOWNSTREAM_OF_ALK_SIGNALING | 1.82e-03 | 11 | 83 | 2 | M42523 | |
| Pathway | KEGG_MEDICUS_REFERENCE_BMP_HAMP_SIGNALING_PATHWAY | 1.82e-03 | 11 | 83 | 2 | M47848 | |
| Pathway | WP_SMC1SMC3_ROLE_IN_DNA_DAMAGE_CORNELIA_DE_LANGE_SYNDROME | 1.82e-03 | 11 | 83 | 2 | M42562 | |
| Pathway | WNT_SIGNALING | 1.87e-03 | 89 | 83 | 4 | M5493 | |
| Pathway | PID_BMP_PATHWAY | 1.91e-03 | 42 | 83 | 3 | M181 | |
| Pathway | REACTOME_DEACTIVATION_OF_THE_BETA_CATENIN_TRANSACTIVATING_COMPLEX | 1.91e-03 | 42 | 83 | 3 | M27272 | |
| Pathway | WP_MESODERMAL_COMMITMENT_PATHWAY | 2.07e-03 | 153 | 83 | 5 | M39546 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_APC_TO_WNT_SIGNALING_PATHWAY | 2.18e-03 | 12 | 83 | 2 | M47410 | |
| Pathway | WP_TGFB_SMAD_SIGNALING | 2.18e-03 | 12 | 83 | 2 | M48091 | |
| Pathway | REACTOME_SIGNALING_BY_TGF_BETA_RECEPTOR_COMPLEX | 2.28e-03 | 94 | 83 | 4 | M1041 | |
| Pathway | WP_NOTCH_SIGNALING_WP268 | 2.34e-03 | 45 | 83 | 3 | M39571 | |
| Pathway | KEGG_MEDICUS_VARIANT_LRP6_OVEREXPRESSION_TO_WNT_SIGNALING_PATHWAY | 2.34e-03 | 45 | 83 | 3 | M47412 | |
| Pathway | REACTOME_GENE_EXPRESSION_TRANSCRIPTION | BRPF3 TCF7 NUP214 NCOR2 KRBA1 KMT2D ATF7IP BRPF1 PAXIP1 TCF7L1 NR1I3 SMAD1 SMAD2 SMAD3 | 2.41e-03 | 1022 | 83 | 14 | MM15436 |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_RUNX3 | 2.46e-03 | 96 | 83 | 4 | M27784 | |
| Pathway | KEGG_MEDICUS_REFERENCE_WNT_SIGNALING_PATHWAY | 2.49e-03 | 46 | 83 | 3 | M47409 | |
| Pathway | WP_NOTCH_SIGNALING_PATHWAY | 2.49e-03 | 46 | 83 | 3 | MM15971 | |
| Pathway | REACTOME_PKMTS_METHYLATE_HISTONE_LYSINES | 2.49e-03 | 46 | 83 | 3 | MM14933 | |
| Pathway | WP_NEURAL_CREST_DIFFERENTIATION | 2.56e-03 | 97 | 83 | 4 | MM15926 | |
| Pathway | REACTOME_NITRIC_OXIDE_STIMULATES_GUANYLATE_CYCLASE | 2.56e-03 | 13 | 83 | 2 | MM15015 | |
| Pathway | WP_BMP2WNT4FOXO1_PATHWAY_IN_PRIMARY_ENDOMETRIAL_STROMAL_CELL_DIFFERENTIATION | 2.56e-03 | 13 | 83 | 2 | M39378 | |
| Pathway | WP_NITRIC_OXIDE_METABOLISM_IN_CYSTIC_FIBROSIS | 2.56e-03 | 13 | 83 | 2 | M39894 | |
| Pathway | REACTOME_TGF_BETA_RECEPTOR_SIGNALING_ACTIVATES_SMADS | 2.65e-03 | 47 | 83 | 3 | M646 | |
| Pathway | KEGG_NOTCH_SIGNALING_PATHWAY | 2.65e-03 | 47 | 83 | 3 | M7946 | |
| Pathway | WP_HIPPO_SIGNALING_REGULATION | 2.65e-03 | 98 | 83 | 4 | M39830 | |
| Pathway | WP_WNT_SIGNALING_AND_PLURIPOTENCY | 2.96e-03 | 101 | 83 | 4 | M39387 | |
| Pathway | WP_NEURAL_CREST_DIFFERENTIATION | 2.96e-03 | 101 | 83 | 4 | M39448 | |
| Pathway | REACTOME_REPRESSION_OF_WNT_TARGET_GENES | 2.98e-03 | 14 | 83 | 2 | M27402 | |
| Pathway | WP_ID_SIGNALING_PATHWAY | 3.16e-03 | 50 | 83 | 3 | MM15817 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_ACTIVITY_OF_SMAD2_SMAD3_SMAD4_HETEROTRIMER | 3.34e-03 | 51 | 83 | 3 | M665 | |
| Pathway | BIOCARTA_HIF_PATHWAY | 3.42e-03 | 15 | 83 | 2 | M13324 | |
| Pathway | REACTOME_SIGNALING_BY_ACTIVIN | 3.42e-03 | 15 | 83 | 2 | MM14593 | |
| Pathway | BIOCARTA_RACC_PATHWAY | 3.42e-03 | 15 | 83 | 2 | M22002 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | SEMA6C PPRC1 POLE KSR2 AKNA GBX2 FRYL NUP214 SRCAP NSD3 FOCAD SNX30 NCOR2 KMT2D BRD2 TULP4 PAXIP1 NAV1 CRAMP1 NOTCH2 ARAP1 | 3.31e-10 | 1105 | 123 | 21 | 35748872 |
| Pubmed | 7.43e-10 | 5 | 123 | 4 | 15647271 | ||
| Pubmed | 7.43e-10 | 5 | 123 | 4 | 19819941 | ||
| Pubmed | 7.43e-10 | 5 | 123 | 4 | 8673135 | ||
| Pubmed | 7.43e-10 | 5 | 123 | 4 | 25141865 | ||
| Pubmed | Control of early fate decisions in human ES cells by distinct states of TGFbeta pathway activity. | 2.22e-09 | 6 | 123 | 4 | 18393632 | |
| Pubmed | 2.22e-09 | 6 | 123 | 4 | 11169847 | ||
| Pubmed | 2.22e-09 | 6 | 123 | 4 | 10400677 | ||
| Pubmed | Smad7 is required for the development and function of the heart. | 2.22e-09 | 6 | 123 | 4 | 18952608 | |
| Pubmed | 2.22e-09 | 6 | 123 | 4 | 11850197 | ||
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | HIF1A ANK3 MAP1B SOBP DTNB GOLM2 KSR2 FRYL JMJD1C SFMBT2 CEP170 SNX30 NCOR2 KCNQ5 TULP4 TJP1 SHPRH NAV1 DLG1 CLEC16A CRAMP1 NOTCH2 ARAP1 | 2.35e-09 | 1489 | 123 | 23 | 28611215 |
| Pubmed | Interaction with Smad4 is indispensable for suppression of BMP signaling by c-Ski. | 5.17e-09 | 7 | 123 | 4 | 14699069 | |
| Pubmed | 5.17e-09 | 7 | 123 | 4 | 10376010 | ||
| Pubmed | Negative regulation of BMP/Smad signaling by Tob in osteoblasts. | 5.17e-09 | 7 | 123 | 4 | 11163184 | |
| Pubmed | 5.17e-09 | 7 | 123 | 4 | 12370310 | ||
| Pubmed | Hgs (Hrs), a FYVE domain protein, is involved in Smad signaling through cooperation with SARA. | 5.17e-09 | 7 | 123 | 4 | 11094085 | |
| Pubmed | 5.17e-09 | 7 | 123 | 4 | 23933588 | ||
| Pubmed | 5.17e-09 | 7 | 123 | 4 | 15009097 | ||
| Pubmed | Activin receptor-like kinase (ALK)1 is an antagonistic mediator of lateral TGFbeta/ALK5 signaling. | 5.17e-09 | 7 | 123 | 4 | 14580334 | |
| Pubmed | ANK3 MAP1B PNN SRCAP JMJD1C NSD3 CEP170 KMT2D ALMS1 TJP1 MDC1 ACIN1 DLG1 WDR44 | 1.01e-08 | 549 | 123 | 14 | 38280479 | |
| Pubmed | 1.03e-08 | 8 | 123 | 4 | 10647776 | ||
| Pubmed | 1.03e-08 | 8 | 123 | 4 | 12714599 | ||
| Pubmed | 1.03e-08 | 8 | 123 | 4 | 10531362 | ||
| Pubmed | A new nonsense mutation of SMAD8 associated with pulmonary arterial hypertension. | 1.03e-08 | 8 | 123 | 4 | 19211612 | |
| Pubmed | 1.03e-08 | 8 | 123 | 4 | 23804438 | ||
| Pubmed | 1.03e-08 | 8 | 123 | 4 | 10708949 | ||
| Pubmed | GATA4 is essential for bone mineralization via ERα and TGFβ/BMP pathways. | 1.85e-08 | 9 | 123 | 4 | 24932701 | |
| Pubmed | 1.85e-08 | 9 | 123 | 4 | 9759503 | ||
| Pubmed | 1.85e-08 | 9 | 123 | 4 | 30134160 | ||
| Pubmed | 1.85e-08 | 9 | 123 | 4 | 24816837 | ||
| Pubmed | 1.85e-08 | 9 | 123 | 4 | 19018011 | ||
| Pubmed | Dullard/Ctdnep1 regulates endochondral ossification via suppression of TGF-β signaling. | 1.85e-08 | 9 | 123 | 4 | 25155999 | |
| Pubmed | 1.85e-08 | 9 | 123 | 4 | 10708948 | ||
| Pubmed | Targeting TRIM37-driven centrosome dysfunction in 17q23-amplified breast cancer. | 2.09e-08 | 184 | 123 | 9 | 32908313 | |
| Pubmed | Disruption of transforming growth factor-beta signaling in ELF beta-spectrin-deficient mice. | 3.08e-08 | 10 | 123 | 4 | 12543979 | |
| Pubmed | TGF-β signaling inhibits canonical BMP signaling pathway during palate development. | 3.08e-08 | 10 | 123 | 4 | 29247325 | |
| Pubmed | 3.08e-08 | 10 | 123 | 4 | 23620745 | ||
| Pubmed | 3.08e-08 | 10 | 123 | 4 | 15221015 | ||
| Pubmed | Protein Arginine Methyltransferase PRMT1 Is Essential for Palatogenesis. | 3.08e-08 | 10 | 123 | 4 | 29986157 | |
| Pubmed | Blockade of Smad signaling by 3'-deoxyadenosine: a mechanism for its anti-fibrotic potential. | 4.32e-08 | 3 | 123 | 3 | 23439432 | |
| Pubmed | Deficiency of MFSD7c results in microcephaly-associated vasculopathy in Fowler syndrome. | 4.69e-08 | 28 | 123 | 5 | 32369449 | |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | MAP1B PNN DDX42 NUP214 JMJD1C NSD3 EFTUD2 CEP170 NCOR2 SALL1 BRD2 G3BP1 TJP1 ATF7IP MDC1 ACIN1 RPS10P5 | 4.79e-08 | 954 | 123 | 17 | 36373674 |
| Pubmed | 4.82e-08 | 11 | 123 | 4 | 24008158 | ||
| Pubmed | Smad2 and Smad3 Regulate Chondrocyte Proliferation and Differentiation in the Growth Plate. | 4.82e-08 | 11 | 123 | 4 | 27741240 | |
| Pubmed | 7.21e-08 | 12 | 123 | 4 | 21538804 | ||
| Pubmed | 7.21e-08 | 12 | 123 | 4 | 17460146 | ||
| Pubmed | 7.21e-08 | 12 | 123 | 4 | 14656760 | ||
| Pubmed | Enhanced BMP signaling results in supernumerary tooth formation in USAG-1 deficient mouse. | 1.04e-07 | 13 | 123 | 4 | 18329379 | |
| Pubmed | 1.04e-07 | 13 | 123 | 4 | 21856951 | ||
| Pubmed | Endoglin is required for myogenic differentiation potential of neural crest stem cells. | 1.04e-07 | 13 | 123 | 4 | 17628518 | |
| Pubmed | Essential functions of Alk3 during AV cushion morphogenesis in mouse embryonic hearts. | 1.04e-07 | 13 | 123 | 4 | 16959237 | |
| Pubmed | Nuclear CDKs drive Smad transcriptional activation and turnover in BMP and TGF-beta pathways. | 1.04e-07 | 13 | 123 | 4 | 19914168 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | FOXM1 PNN CKAP5 NUP214 EFTUD2 NCOR2 KMT2D BRD2 G3BP1 BRPF1 MDC1 ACIN1 DLG1 NOTCH2 WDR44 | 1.08e-07 | 774 | 123 | 15 | 15302935 |
| Pubmed | A census of human transcription factors: function, expression and evolution. | FOXM1 HIF1A TCF7 ETV7 AKNA GBX2 FOSL1 KMT2D SALL1 TCF7L1 CRAMP1 NR1I3 SMAD1 SMAD2 SMAD3 SMAD5 | 1.43e-07 | 908 | 123 | 16 | 19274049 |
| Pubmed | Matrix GLA protein, an inhibitory morphogen in pulmonary vascular development. | 1.45e-07 | 14 | 123 | 4 | 17670744 | |
| Pubmed | 1.45e-07 | 14 | 123 | 4 | 16790475 | ||
| Pubmed | 1.45e-07 | 14 | 123 | 4 | 25274628 | ||
| Pubmed | 1.45e-07 | 14 | 123 | 4 | 38951500 | ||
| Pubmed | Loss of Smad4 in the scleraxis cell lineage results in postnatal joint contracture. | 1.45e-07 | 14 | 123 | 4 | 33248111 | |
| Pubmed | 1.45e-07 | 14 | 123 | 4 | 16435884 | ||
| Pubmed | 1.72e-07 | 4 | 123 | 3 | 9111321 | ||
| Pubmed | 1.72e-07 | 4 | 123 | 3 | 11016919 | ||
| Pubmed | Structural basis for the cooperative DNA recognition by Smad4 MH1 dimers. | 1.72e-07 | 4 | 123 | 3 | 21724602 | |
| Pubmed | A novel ability of Smad3 to regulate proteasomal degradation of a Cas family member HEF1. | 1.72e-07 | 4 | 123 | 3 | 11118211 | |
| Pubmed | 1.72e-07 | 4 | 123 | 3 | 19247629 | ||
| Pubmed | Role of SARA (SMAD anchor for receptor activation) in maintenance of epithelial cell phenotype. | 1.72e-07 | 4 | 123 | 3 | 19620243 | |
| Pubmed | Fussel-15, a novel Ski/Sno homolog protein, antagonizes BMP signaling. | 1.72e-07 | 4 | 123 | 3 | 17292623 | |
| Pubmed | Regulation of Smad degradation and activity by Smurf2, an E3 ubiquitin ligase. | 1.72e-07 | 4 | 123 | 3 | 11158580 | |
| Pubmed | Functions of mammalian Smad genes as revealed by targeted gene disruption in mice. | 1.72e-07 | 4 | 123 | 3 | 10708952 | |
| Pubmed | FOXM1 HIF1A TCF7 GBX2 SRCAP KRBA1 SALL1 BRD2 BRPF1 ACIN1 TCF7L1 SMAD1 SMAD2 SMAD3 ZNF292 | 1.87e-07 | 808 | 123 | 15 | 20412781 | |
| Pubmed | USP13 ANK3 NCOR2 KMT2D ZFYVE9 ATF7IP PAXIP1 RUBCN NOTCH2 SMAD1 SMAD2 SMAD3 SMAD5 | 1.93e-07 | 591 | 123 | 13 | 15231748 | |
| Pubmed | 1.97e-07 | 15 | 123 | 4 | 18548003 | ||
| Pubmed | 1.97e-07 | 15 | 123 | 4 | 23011393 | ||
| Pubmed | 1.97e-07 | 15 | 123 | 4 | 23946498 | ||
| Pubmed | 2.62e-07 | 16 | 123 | 4 | 21939397 | ||
| Pubmed | Smad7 regulates terminal maturation of chondrocytes in the growth plate. | 3.42e-07 | 17 | 123 | 4 | 23994637 | |
| Pubmed | Cellular response to hypoxia involves signaling via Smad proteins. | 4.29e-07 | 5 | 123 | 3 | 12411310 | |
| Pubmed | Distinct domain utilization by Smad3 and Smad4 for nucleoporin interaction and nuclear import. | 4.29e-07 | 5 | 123 | 3 | 12917407 | |
| Pubmed | USP15 is a deubiquitylating enzyme for receptor-activated SMADs. | 4.29e-07 | 5 | 123 | 3 | 21947082 | |
| Pubmed | The MH1 domain of Smad3 interacts with Pax6 and represses autoregulation of the Pax6 P1 promoter. | 4.29e-07 | 5 | 123 | 3 | 17251190 | |
| Pubmed | 4.29e-07 | 5 | 123 | 3 | 18566469 | ||
| Pubmed | Carboxy-terminally truncated Gli3 proteins associate with Smads. | 4.29e-07 | 5 | 123 | 3 | 9843199 | |
| Pubmed | 4.29e-07 | 5 | 123 | 3 | 21976486 | ||
| Pubmed | 4.29e-07 | 5 | 123 | 3 | 11387330 | ||
| Pubmed | 4.29e-07 | 5 | 123 | 3 | 12808092 | ||
| Pubmed | Two short segments of Smad3 are important for specific interaction of Smad3 with c-Ski and SnoN. | 4.29e-07 | 5 | 123 | 3 | 12426322 | |
| Pubmed | E1A inhibits transforming growth factor-beta signaling through binding to Smad proteins. | 4.29e-07 | 5 | 123 | 3 | 10497242 | |
| Pubmed | 4.29e-07 | 5 | 123 | 3 | 24760996 | ||
| Pubmed | The liver-enriched lnc-LFAR1 promotes liver fibrosis by activating TGFβ and Notch pathways. | 4.29e-07 | 5 | 123 | 3 | 28747678 | |
| Pubmed | Opposing functions of ZEB proteins in the regulation of the TGFbeta/BMP signaling pathway. | 4.29e-07 | 5 | 123 | 3 | 12743038 | |
| Pubmed | 4.39e-07 | 18 | 123 | 4 | 18664271 | ||
| Pubmed | 4.39e-07 | 18 | 123 | 4 | 27720610 | ||
| Pubmed | 4.39e-07 | 18 | 123 | 4 | 23546880 | ||
| Pubmed | 5.54e-07 | 19 | 123 | 4 | 21957238 | ||
| Pubmed | 5.54e-07 | 19 | 123 | 4 | 23776616 | ||
| Pubmed | Fgf9 signaling regulates small intestinal elongation and mesenchymal development. | 6.91e-07 | 20 | 123 | 4 | 18653563 | |
| Pubmed | RAB23 coordinates early osteogenesis by repressing FGF10-pERK1/2 and GLI1. | 6.91e-07 | 20 | 123 | 4 | 32662771 | |
| Pubmed | 8.57e-07 | 6 | 123 | 3 | 19135894 | ||
| Pubmed | Phosphorylation of Smad signaling proteins by receptor serine/threonine kinases. | 8.57e-07 | 6 | 123 | 3 | 11100470 | |
| Pubmed | 8.57e-07 | 6 | 123 | 3 | 21518886 | ||
| Interaction | SOX7 interactions | 5.85e-07 | 82 | 120 | 7 | int:SOX7 | |
| Interaction | GSC interactions | 8.77e-07 | 87 | 120 | 7 | int:GSC | |
| Interaction | ZMYND11 interactions | 1.48e-06 | 94 | 120 | 7 | int:ZMYND11 | |
| Interaction | TOP3B interactions | SEMA6C PPRC1 POLE KSR2 AKNA GBX2 FRYL NUP214 SRCAP NSD3 FOCAD SNX30 NCOR2 KMT2D BRD2 G3BP1 TULP4 MDC1 PAXIP1 NAV1 ACIN1 CRAMP1 NOTCH2 ARAP1 | 5.09e-06 | 1470 | 120 | 24 | int:TOP3B |
| Interaction | HNF4A interactions | HIF1A SRCAP NCOR2 KMT2D BRD2 ATF7IP PAXIP1 NR1I3 SMAD2 SMAD3 | 5.90e-06 | 275 | 120 | 10 | int:HNF4A |
| Interaction | CTNNB1 interactions | FOXM1 ARHGAP32 USP13 HIF1A TCF7 ANK3 NTRK3 RAB11A NUP214 EFTUD2 KMT2D SALL1 ZFYVE9 G3BP1 TJP1 DLG1 TCF7L1 SMAD2 SMAD3 | 7.93e-06 | 1009 | 120 | 19 | int:CTNNB1 |
| Interaction | WWTR1 interactions | ANK3 MAP1B PNN SRCAP JMJD1C CEP170 KMT2D ALMS1 TJP1 DLG1 SMAD2 WDR44 | 8.35e-06 | 422 | 120 | 12 | int:WWTR1 |
| Interaction | TNIK interactions | ARHGAP32 ANK3 NTRK3 RAPGEF4 EFTUD2 CEP170 NCOR2 G3BP1 TJP1 DLG1 NOS1 | 1.76e-05 | 381 | 120 | 11 | int:TNIK |
| Interaction | YAP1 interactions | HIF1A ANK3 PNN CKAP5 SRCAP JMJD1C NSD3 CEP170 KMT2D BRD2 TULP4 TJP1 MDC1 ACIN1 DLG1 SMAD1 SMAD2 SMAD3 SMAD5 | 2.49e-05 | 1095 | 120 | 19 | int:YAP1 |
| Interaction | RUNX3 interactions | 3.14e-05 | 61 | 120 | 5 | int:RUNX3 | |
| Interaction | MEN1 interactions | PNN DDX42 SRCAP JMJD1C NSD3 FOSL1 EFTUD2 KMT2D G3BP1 TJP1 BRPF1 MDC1 PAXIP1 ACIN1 SMAD1 SMAD2 SMAD3 SMAD5 | 3.75e-05 | 1029 | 120 | 18 | int:MEN1 |
| Interaction | NFIC interactions | 3.77e-05 | 210 | 120 | 8 | int:NFIC | |
| Interaction | PELO interactions | 5.09e-05 | 161 | 120 | 7 | int:PELO | |
| Interaction | SVEP1 interactions | 5.64e-05 | 13 | 120 | 3 | int:SVEP1 | |
| Interaction | ETV4 interactions | 5.71e-05 | 69 | 120 | 5 | int:ETV4 | |
| Interaction | CDK9 interactions | VIL1 HIF1A PNN DDX42 CKAP5 NUP214 SRCAP EFTUD2 TJP1 PAXIP1 ACIN1 SMAD1 SMAD2 SMAD3 | 5.80e-05 | 685 | 120 | 14 | int:CDK9 |
| Interaction | H2BC21 interactions | BRPF3 MAP1B PNN FAM47B SRCAP JMJD1C SFMBT2 NSD3 DNAAF2 BRD2 BRPF1 MDC1 SHPRH ZNF292 | 6.88e-05 | 696 | 120 | 14 | int:H2BC21 |
| Interaction | H2BC9 interactions | HIF1A MAP1B PNN CKAP5 FAM47B PDZD7 SFMBT2 FSIP2 ZNF469 MDC1 CFAP44 | 7.35e-05 | 446 | 120 | 11 | int:H2BC9 |
| Interaction | PARD3 interactions | 7.46e-05 | 298 | 120 | 9 | int:PARD3 | |
| Interaction | SMC5 interactions | MAP1B PNN DDX42 NUP214 JMJD1C NSD3 EFTUD2 CEP170 NCOR2 SALL1 BRD2 G3BP1 TJP1 ATF7IP MDC1 ACIN1 RPS10P5 | 8.94e-05 | 1000 | 120 | 17 | int:SMC5 |
| Interaction | YWHAH interactions | LGMN ARHGAP32 PNN TRPM7 KSR2 CKAP5 FRYL NSD3 EFTUD2 CEP170 KCNQ5 ALMS1 G3BP1 TJP1 NAV1 CLEC16A RUBCN NOTCH2 | 9.05e-05 | 1102 | 120 | 18 | int:YWHAH |
| Interaction | SIN3A interactions | BRPF3 HIF1A MAP1B EFTUD2 NCOR2 MDC1 SHPRH LRCH4 NOTCH2 SMAD3 | 9.30e-05 | 380 | 120 | 10 | int:SIN3A |
| Interaction | NCK1 interactions | 1.08e-04 | 244 | 120 | 8 | int:NCK1 | |
| Interaction | BCR interactions | 1.08e-04 | 244 | 120 | 8 | int:BCR | |
| Interaction | MAPT interactions | LGMN BRPF3 DIS3L2 ANK3 MAP1B MAP6 RAB11A CKAP5 GATM FRYL PDHX CEP170 DNAAF2 FSIP2 G3BP1 TJP1 DLG1 SMAD2 | 1.10e-04 | 1119 | 120 | 18 | int:MAPT |
| Interaction | MED24 interactions | 1.18e-04 | 128 | 120 | 6 | int:MED24 | |
| Interaction | FHL1 interactions | 1.23e-04 | 129 | 120 | 6 | int:FHL1 | |
| Interaction | MED15 interactions | 1.34e-04 | 131 | 120 | 6 | int:MED15 | |
| Interaction | NFIA interactions | 1.35e-04 | 188 | 120 | 7 | int:NFIA | |
| Interaction | TOB1 interactions | 1.35e-04 | 44 | 120 | 4 | int:TOB1 | |
| Interaction | GLUD1 interactions | 1.58e-04 | 258 | 120 | 8 | int:GLUD1 | |
| Interaction | PFKM interactions | 1.58e-04 | 193 | 120 | 7 | int:PFKM | |
| Interaction | TAF1 interactions | 1.67e-04 | 260 | 120 | 8 | int:TAF1 | |
| Interaction | GTF2IRD1 interactions | 1.82e-04 | 88 | 120 | 5 | int:GTF2IRD1 | |
| Interaction | HMGA2 interactions | 1.93e-04 | 140 | 120 | 6 | int:HMGA2 | |
| Interaction | RADX interactions | 2.06e-04 | 49 | 120 | 4 | int:RADX | |
| Interaction | RASL12 interactions | 2.18e-04 | 20 | 120 | 3 | int:RASL12 | |
| Interaction | USP9X interactions | 2.18e-04 | 422 | 120 | 10 | int:USP9X | |
| Interaction | NCOA6 interactions | 2.33e-04 | 145 | 120 | 6 | int:NCOA6 | |
| Interaction | CPSF3 interactions | 2.42e-04 | 146 | 120 | 6 | int:CPSF3 | |
| Interaction | CREBBP interactions | FOXM1 HIF1A MAP1B SRCAP FOSL1 NCOR2 KMT2D ATF7IP MDC1 SMAD1 SMAD2 SMAD3 | 2.42e-04 | 599 | 120 | 12 | int:CREBBP |
| Interaction | ZNF251 interactions | 2.53e-04 | 21 | 120 | 3 | int:ZNF251 | |
| Interaction | NOTCH4 interactions | 2.53e-04 | 21 | 120 | 3 | int:NOTCH4 | |
| Interaction | NOSIP interactions | 2.60e-04 | 95 | 120 | 5 | int:NOSIP | |
| Interaction | FOXG1 interactions | 2.60e-04 | 95 | 120 | 5 | int:FOXG1 | |
| Interaction | AR interactions | HIF1A PNN DDX42 SRCAP JMJD1C EFTUD2 NCOR2 KMT2D BRD2 G3BP1 TJP1 MDC1 PAXIP1 ACIN1 SMAD1 SMAD3 | 2.66e-04 | 992 | 120 | 16 | int:AR |
| Interaction | PAPPA interactions | 2.92e-04 | 22 | 120 | 3 | int:PAPPA | |
| Interaction | HOXA13 interactions | 2.92e-04 | 22 | 120 | 3 | int:HOXA13 | |
| Interaction | H3C1 interactions | ANK3 DDX42 RAB11A SRCAP JMJD1C NSD3 EFTUD2 KMT2D BRD2 BRPF1 MDC1 PAXIP1 SHPRH PRR14L ZNF292 | 3.00e-04 | 901 | 120 | 15 | int:H3C1 |
| Interaction | ZNF518A interactions | 3.00e-04 | 54 | 120 | 4 | int:ZNF518A | |
| Interaction | RNF168 interactions | 3.01e-04 | 98 | 120 | 5 | int:RNF168 | |
| Interaction | HDAC1 interactions | HIF1A TRPM7 CKAP5 NUP214 JMJD1C FOSL1 EFTUD2 NCOR2 KMT2D SALL1 ALMS1 G3BP1 NAV1 SMAD1 SMAD2 SMAD3 SMAD5 | 3.03e-04 | 1108 | 120 | 17 | int:HDAC1 |
| Interaction | SMAD9 interactions | 3.11e-04 | 153 | 120 | 6 | int:SMAD9 | |
| Interaction | KLHL20 interactions | 3.15e-04 | 216 | 120 | 7 | int:KLHL20 | |
| Interaction | IRF7 interactions | 3.30e-04 | 100 | 120 | 5 | int:IRF7 | |
| Interaction | CITED2 interactions | 3.34e-04 | 23 | 120 | 3 | int:CITED2 | |
| Interaction | SMAD5 interactions | 3.46e-04 | 101 | 120 | 5 | int:SMAD5 | |
| Interaction | PAX6 interactions | 3.47e-04 | 366 | 120 | 9 | int:PAX6 | |
| Interaction | NUP43 interactions | PNN NUP214 SRCAP JMJD1C NSD3 FSIP2 NCOR2 KMT2D ATF7IP MDC1 ACIN1 ZNF292 | 3.56e-04 | 625 | 120 | 12 | int:NUP43 |
| Interaction | MED4 interactions | MAP1B CKAP5 CEP170 ALMS1 ATF7IP NAV1 NR1I3 SMAD1 SMAD2 SMAD3 | 3.63e-04 | 450 | 120 | 10 | int:MED4 |
| Interaction | CDK8 interactions | 3.72e-04 | 222 | 120 | 7 | int:CDK8 | |
| Interaction | KDM1B interactions | 3.96e-04 | 58 | 120 | 4 | int:KDM1B | |
| Interaction | ETV6 interactions | 4.14e-04 | 105 | 120 | 5 | int:ETV6 | |
| Interaction | SOX5 interactions | 4.22e-04 | 162 | 120 | 6 | int:SOX5 | |
| Interaction | RASD2 interactions | 4.30e-04 | 25 | 120 | 3 | int:RASD2 | |
| Interaction | EXOC2 interactions | 4.32e-04 | 106 | 120 | 5 | int:EXOC2 | |
| Interaction | PML interactions | FOXM1 MAP1B DDX42 JMJD1C CEP170 NCOR2 ZFYVE9 TJP1 ATF7IP MDC1 PAXIP1 SHPRH NR1I3 SMAD2 SMAD3 | 4.33e-04 | 933 | 120 | 15 | int:PML |
| Interaction | PIN1 interactions | 4.82e-04 | 383 | 120 | 9 | int:PIN1 | |
| Interaction | BUB3 interactions | 4.84e-04 | 232 | 120 | 7 | int:BUB3 | |
| Cytoband | 7q36 | 5.24e-05 | 27 | 123 | 3 | 7q36 | |
| GeneFamily | SMAD family | 1.89e-08 | 8 | 75 | 4 | 750 | |
| GeneFamily | PHD finger proteins | 3.58e-05 | 90 | 75 | 5 | 88 | |
| GeneFamily | PWWP domain containing | 9.98e-05 | 22 | 75 | 3 | 1147 | |
| GeneFamily | Ataxins|Trinucleotide repeat containing | 1.48e-04 | 25 | 75 | 3 | 775 | |
| GeneFamily | Sorting nexins|PX-BAR domain containing | 1.09e-03 | 12 | 75 | 2 | 1290 | |
| GeneFamily | PDZ domain containing | 3.67e-03 | 152 | 75 | 4 | 1220 | |
| GeneFamily | Guanylate cyclase receptors|DENN/MADD domain containing | 4.79e-03 | 25 | 75 | 2 | 504 | |
| GeneFamily | Calcium voltage-gated channel subunits|Membrane associated guanylate kinases | 5.17e-03 | 26 | 75 | 2 | 904 | |
| Coexpression | GSE21379_TFH_VS_NON_TFH_CD4_TCELL_UP | GOLM2 DDX42 FRYL SRCAP JMJD1C NSD3 TULP4 ATF7IP NOTCH2 WDR44 | 2.55e-08 | 200 | 118 | 10 | M7500 |
| Coexpression | GSE40274_CTRL_VS_EOS_TRANSDUCED_ACTIVATED_CD4_TCELL_DN | 4.10e-07 | 150 | 118 | 8 | M9139 | |
| Coexpression | AIZARANI_LIVER_C20_LSECS_3 | 7.85e-06 | 295 | 118 | 9 | M39121 | |
| Coexpression | AIZARANI_LIVER_C9_LSECS_1 | 9.99e-06 | 304 | 118 | 9 | M39113 | |
| Coexpression | NAKAYA_B_CELL_FLUMIST_AGE_18_50YO_7DY_UP | FOXM1 ANK3 PNN GBX2 FRYL PDHX CEP170 DTX4 DENND4B DLG1 SMAD3 | 1.03e-05 | 475 | 118 | 11 | M40979 |
| Coexpression | GSE14415_INDUCED_TREG_VS_FOXP3_KO_INDUCED_TREG_UP | 1.33e-05 | 172 | 118 | 7 | M2951 | |
| Coexpression | GU_PDEF_TARGETS_UP | 1.74e-05 | 71 | 118 | 5 | M3955 | |
| Coexpression | GSE27241_WT_VS_RORGT_KO_TH17_POLARIZED_CD4_TCELL_TREATED_WITH_DIGOXIN_UP | 1.78e-05 | 180 | 118 | 7 | M8239 | |
| Coexpression | TURJANSKI_MAPK1_AND_MAPK2_TARGETS | 1.90e-05 | 12 | 118 | 3 | M15804 | |
| Coexpression | GSE2770_TGFB_AND_IL4_VS_IL4_TREATED_ACT_CD4_TCELL_6H_UP | 2.88e-05 | 194 | 118 | 7 | M6103 | |
| Coexpression | GSE1740_MCSF_VS_MCSF_AND_IFNG_DAY2_DERIVED_MACROPHAGE_DN | 3.39e-05 | 199 | 118 | 7 | M6157 | |
| Coexpression | HALLMARK_UV_RESPONSE_DN | 4.92e-05 | 144 | 118 | 6 | M5942 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN | USP13 MAP1B CKAP5 FRYL CEP170 ZFYVE9 NAA20 CLEC16A SMAD3 ZNF292 | 5.04e-05 | 466 | 118 | 10 | M13522 |
| Coexpression | GSE14699_NAIVE_VS_DELETIONAL_TOLERANCE_CD8_TCELL_UP | 6.65e-05 | 152 | 118 | 6 | M2938 | |
| Coexpression | HALLMARK_TGF_BETA_SIGNALING | 1.04e-04 | 54 | 118 | 4 | M5896 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | USP13 HIF1A MAP1B DDX42 CKAP5 FRYL CEP170 NCOR2 ZFYVE9 DLG1 CLEC16A SMAD3 ZNF292 | 1.30e-04 | 856 | 118 | 13 | M4500 |
| CoexpressionAtlas | DevelopingKidney_e15.5_Cap mesenchyme_emap-27738_top-relative-expression-ranked_1000 | ANK3 PNN TRPM7 SOBP GOLM2 POLE CKAP5 FRYL NUP214 SRCAP LCP2 SFMBT2 NSD3 SALL1 PAXIP1 SMAD5 ZNF292 | 1.13e-06 | 779 | 116 | 17 | gudmap_developingKidney_e15.5_Cap mesenchyme_1000 |
| CoexpressionAtlas | DevelopingKidney_e15.5_Cap mesenchyme_emap-27738_k-means-cluster#1_top-relative-expression-ranked_1000 | 7.15e-06 | 241 | 116 | 9 | gudmap_developingKidney_e15.5_Cap mesenchyme_1000_k1 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_1000_k-means-cluster#1 | 1.27e-05 | 259 | 116 | 9 | Facebase_RNAseq_e8.5_Floor Plate_1000_K1 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_2500_k-means-cluster#3 | USP13 MAP1B PNN POLE CKAP5 DNAAF2 ALMS1 TJP1 DTX4 PAXIP1 ACIN1 WDR44 | 3.50e-05 | 532 | 116 | 12 | Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_2500_K3 |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_top-relative-expression-ranked_1000 | SEMA6C C1orf54 TRPM7 NTRK3 DDX42 SRCAP JMJD1C NSD3 SULT1E1 FZD4 BRD2 DTX4 NAV1 ACIN1 | 1.18e-04 | 799 | 116 | 14 | gudmap_developingGonad_e18.5_epididymis_1000 |
| CoexpressionAtlas | DevelopingKidney_e15.5_Cap mesenchyme_emap-27738_k-means-cluster#5_top-relative-expression-ranked_1000 | 1.52e-04 | 146 | 116 | 6 | gudmap_developingKidney_e15.5_Cap mesenchyme_1000_k5 | |
| CoexpressionAtlas | dev gonad_e11.5_F_ReproVasc_Flk_k-means-cluster#3_top-relative-expression-ranked_1000 | LGMN C1orf54 RAPGEF4 LCP2 JMJD1C INPP4B FZD4 TJP1 ARHGAP27 NOS3 | 1.64e-04 | 444 | 116 | 10 | gudmap_dev gonad_e11.5_F_ReproVasc_Flk_k3_1000 |
| ToppCell | CV-Healthy-3|Healthy / Virus stimulation, Condition and Cluster | 1.95e-07 | 154 | 119 | 7 | 26bf81a86700db7e65c2384ffe94ed4253ea4047 | |
| ToppCell | CV-Moderate-7|Moderate / Virus stimulation, Condition and Cluster | 6.74e-07 | 185 | 119 | 7 | a6c9203ce6c2892a4a369c9bcfb85720f01cbb3f | |
| ToppCell | -Unknown-Endothelial-Myofibroblast| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.51e-07 | 188 | 119 | 7 | 6468fa95ad0395395301115286f2d8c0df5d3882 | |
| ToppCell | -Unknown-Endothelial| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.51e-07 | 188 | 119 | 7 | 7a81ac5c79c3eb26639b52d2b9fd5e7ef9798fd6 | |
| ToppCell | -Unknown| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.51e-07 | 188 | 119 | 7 | 9cb718bfe1358c6fd842f096e228eb0abb9aefc6 | |
| ToppCell | PBMC-Control-cDC_3|Control / Compartment, Disease Groups and Clusters | 9.92e-07 | 196 | 119 | 7 | 09d197b321ff9f13c0672ea059c850845b0dbbd5 | |
| ToppCell | 3'_v3-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 2.81e-06 | 147 | 119 | 6 | 94998bc40f5c08295cfe3bdcbe43f13b1e564b3d | |
| ToppCell | PBMC-Severe-Myeloid-cDC-cDC-cDC_11|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 3.68e-06 | 154 | 119 | 6 | 5967a0a33456d5930fc492a700ebb015ac050abb | |
| ToppCell | PBMC-Severe-Myeloid-cDC-cDC-cDC_11|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.82e-06 | 155 | 119 | 6 | fab281db4c275d51240b122be78713c839ba5a95 | |
| ToppCell | severe_COVID-19-cDC|World / disease group, cell group and cell class (v2) | 3.96e-06 | 156 | 119 | 6 | 0a7e18ed8e13261c405eb6b9a183e99d8e1aac37 | |
| ToppCell | CV-Healthy-3|CV / Virus stimulation, Condition and Cluster | 4.75e-06 | 161 | 119 | 6 | fd4a79385ea967b9900dc76a3add813b894a3a28 | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Neuronal-neurons_B|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.30e-05 | 192 | 119 | 6 | 2f1c4ef693515ccc7231bd8c6641fad51d445d20 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.42e-05 | 195 | 119 | 6 | 2e1df01bf6e4e98e6cd9fb50926e34c5077b8666 | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Endothelial-blood_vessel_EC|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.55e-05 | 198 | 119 | 6 | 5b86dc00acf8ac2ede008f5d79c09996485bf250 | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Endothelial|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.55e-05 | 198 | 119 | 6 | 13203249e5743ba2699871c184d141207e550a86 | |
| ToppCell | mild-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.59e-05 | 199 | 119 | 6 | f0b0097df0026496470a80d8cc9375ffd8389b00 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_|World / Primary Cells by Cluster | 1.59e-05 | 199 | 119 | 6 | 058373b4ac3cec2108cb24265628ff0a50646e33 | |
| ToppCell | Neuronal|World / cells hierarchy compared to all cells using T-Statistic | 1.64e-05 | 200 | 119 | 6 | 48d801219bc771d6c7e151dc88ca4c179988de85 | |
| ToppCell | Control_saline-Endothelial-Endothelial-Gen_Cap|Control_saline / Treatment groups by lineage, cell group, cell type | 1.64e-05 | 200 | 119 | 6 | 3b97920e1e6e2f09ddba2a861baa9c00c2970f4c | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.64e-05 | 200 | 119 | 6 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial-Gen_Cap|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.64e-05 | 200 | 119 | 6 | a2b9d1cd291d17abddc3ee2e242121412c864b8b | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c06-TNF|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.73e-05 | 140 | 119 | 5 | 276b3fa924176426efb31112ed4d355407f0b218 | |
| ToppCell | severe_COVID-19-cDC|severe_COVID-19 / disease group, cell group and cell class (v2) | 6.43e-05 | 157 | 119 | 5 | ec1978e07e2214048d015d8bb793c1d9991f6e37 | |
| ToppCell | Severe-B_naive-5|Severe / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 6.43e-05 | 157 | 119 | 5 | a57ee4a6febdff3ee3d1645836695e6e7c055cf8 | |
| ToppCell | T_cells-Tph_and_Tfh|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 7.46e-05 | 162 | 119 | 5 | 146058f2d60846376078916055d08f68562e3a7c | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-DC-DC1-B|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 8.37e-05 | 166 | 119 | 5 | c8a7d94ed762e5e045ab5f74eef691ddc5f74993 | |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 9.63e-05 | 171 | 119 | 5 | 2e9a20f8980b78325c52065a9c14ab3656267c05 | |
| ToppCell | facs-Spleen-nan-24m-Lymphocytic-Cd3e_T_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.02e-04 | 173 | 119 | 5 | f2eeff86e7dc7f4e3c36f775777d56685d7096cf | |
| ToppCell | PBMC-Control-Myeloid-cDC-cDC-cDC_10|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.02e-04 | 173 | 119 | 5 | 09a13407a41ff2cba82fc417b72bf9a24ce6c42e | |
| ToppCell | PBMC-Control-Myeloid-cDC-cDC-cDC_10|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.02e-04 | 173 | 119 | 5 | bfec038a6783f166240da4861e100643c6ea80a5 | |
| ToppCell | PND07-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC-AEC_prolif|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.02e-04 | 173 | 119 | 5 | 4968712af1cca8c932abd3323631d7dcaffd4a66 | |
| ToppCell | facs-Trachea-18m-Endothelial-endothelial_cell_of_trachea-tracheal_endothelial_cell-tracheal_endothelial_cell_l27|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.02e-04 | 173 | 119 | 5 | ad9777e4ae70b11676ec735eb6db91776ca0cb19 | |
| ToppCell | facs-Lung-nan-3m-Lymphocytic-CD8-positive,_alpha-beta_T_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.04e-04 | 174 | 119 | 5 | 1c073177c1753e3b91ef8fd9e95230a1d13c82f3 | |
| ToppCell | facs-Lung-nan-3m-Lymphocytic-CD8+_T|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.04e-04 | 174 | 119 | 5 | 5491ad5c144baf2ef9b1c58eb720c872d14feb15 | |
| ToppCell | droplet-Heart-nan-3m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.10e-04 | 176 | 119 | 5 | 749b47eac5436fa34e0d243ffbc6f1897f4e431e | |
| ToppCell | PND01-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC-LEC_prolif|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.10e-04 | 176 | 119 | 5 | a9e77681bcd36c382d53eb6f771349d55f98d744 | |
| ToppCell | facs-Trachea-18m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l32-30|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.13e-04 | 177 | 119 | 5 | 59cf56c385c324f0844f20003d2b5049a2791e45 | |
| ToppCell | facs-Marrow-T_cells-18m-Lymphocytic-BM_CD4_T_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.16e-04 | 178 | 119 | 5 | 888add8935ef3aef9b6693c5698e9d1842e66337 | |
| ToppCell | facs-Marrow-T_cells-18m-Lymphocytic-CD4-positive,_alpha-beta_T_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.16e-04 | 178 | 119 | 5 | 43eda32af2e5e28a92421612d0a4c21e5427a772 | |
| ToppCell | Endothelial-A-IPF_04|World / lung cells shred on cell class, cell subclass, sample id | 1.16e-04 | 178 | 119 | 5 | 2f2602b9305d55f25afa9861dd6c6347ae179337 | |
| ToppCell | facs-Heart-RA-3m-Lymphocytic|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.16e-04 | 178 | 119 | 5 | ba6ded4455233635a11afcf6f522c786bd81b5e0 | |
| ToppCell | 3'_v3-lymph-node_spleen-Myeloid_Dendritic-DC1|lymph-node_spleen / Manually curated celltypes from each tissue | 1.22e-04 | 180 | 119 | 5 | a7db1f00566c9acab8b239cbf2e053fb3f2f6a0d | |
| ToppCell | IIH-Treg-proli_CD4|IIH / Condition, Cell_class and T cell subcluster | 1.29e-04 | 182 | 119 | 5 | 5c7d02da9ca2bca49db9832704b6894dfaa08a71 | |
| ToppCell | COVID-19-Heart-CM_3|Heart / Disease (COVID-19 only), tissue and cell type | 1.29e-04 | 182 | 119 | 5 | 287fcc3897ae08841f6f85ae6c9cef16f75b1dd1 | |
| ToppCell | COVID-19-kidney-Mito-rich_EC|kidney / Disease (COVID-19 only), tissue and cell type | 1.32e-04 | 183 | 119 | 5 | 3c4153479fc4ab2d073d92cee120480015555914 | |
| ToppCell | COVID-19-kidney-Podocyte|kidney / Disease (COVID-19 only), tissue and cell type | 1.32e-04 | 183 | 119 | 5 | fb5e2a31b560126e1c04a386c24c365901c60ad7 | |
| ToppCell | droplet-Spleen-nan-18m-Lymphocytic-T_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.36e-04 | 184 | 119 | 5 | 8c23945bafe8926f25836bc208115edd5214a2b0 | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Lymphocytic-CD45____T_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.36e-04 | 184 | 119 | 5 | 2c8e9ddce3e60302965dcf9dee77c4fe33e4071d | |
| ToppCell | (7)_DC_activated|World / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 1.36e-04 | 184 | 119 | 5 | b89871a3e36fde6daa68daf116f8c8d587554c0f | |
| ToppCell | Control-T_cells-CD8+_T_cells|Control / group, cell type (main and fine annotations) | 1.39e-04 | 185 | 119 | 5 | 02ab64c0166c0646d1d4c6ed110ef0b75a1096d0 | |
| ToppCell | Control-Epithelial-Basal|Epithelial / Disease state, Lineage and Cell class | 1.39e-04 | 185 | 119 | 5 | d5d6d13e2f20b54ca55645b9a757b8599f4fd897 | |
| ToppCell | CV-Moderate-7|CV / Virus stimulation, Condition and Cluster | 1.43e-04 | 186 | 119 | 5 | 8571956890fc9894d766ba294a28e376b4aba428 | |
| ToppCell | Control-T_cells|Control / group, cell type (main and fine annotations) | 1.46e-04 | 187 | 119 | 5 | f4e8e0eba58da89b56587667555a5d4754e108c7 | |
| ToppCell | COPD-Epithelial-ATII|Epithelial / Disease state, Lineage and Cell class | 1.46e-04 | 187 | 119 | 5 | 030af361f8bdcd0aff4ec1922702833325cf74d8 | |
| ToppCell | facs-Kidney-nan-3m-Epithelial-kidney_collecting_duct_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.50e-04 | 188 | 119 | 5 | b483b4629695764568bcbd1d527d614824147783 | |
| ToppCell | 15-Distal-Mesenchymal-Pericyte|Distal / Age, Tissue, Lineage and Cell class | 1.50e-04 | 188 | 119 | 5 | 4963382e54aac06bf5047c7d725393db70667ee7 | |
| ToppCell | facs-Kidney-nan-3m-Epithelial-kidney_collecting_duct_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.50e-04 | 188 | 119 | 5 | c1f64311ff05093b2f4f672e33f5f75e3bc8a8db | |
| ToppCell | Endothelial-A-SSc-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 1.50e-04 | 188 | 119 | 5 | 0824d567356d360fd8e78e840c30529c139f98a1 | |
| ToppCell | ILEUM-inflamed-(5)_Plasma-(5)_IgA_plasma_cells|(5)_Plasma / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 1.54e-04 | 189 | 119 | 5 | a0634d72bfdd5f93877724ed6480b50a3a046f71 | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_myocytic-mes_pericyte_(14)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.58e-04 | 190 | 119 | 5 | 10125091ad648163777b02e9f0d5e8d7f17d44a5 | |
| ToppCell | E16.5-samps-Endothelial-Immature_fetal_endothelial|E16.5-samps / Age Group, Lineage, Cell class and subclass | 1.62e-04 | 191 | 119 | 5 | 44c596984c6196f6014e0e405dbe5560841e54ff | |
| ToppCell | PND07-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.62e-04 | 191 | 119 | 5 | 3307dbccadb09c62b0e1c0235ec89bb294d748c3 | |
| ToppCell | E16.5-samps-Endothelial|E16.5-samps / Age Group, Lineage, Cell class and subclass | 1.62e-04 | 191 | 119 | 5 | e7521d4d24f016d4e531cd492a7a69604f0c9e6f | |
| ToppCell | COVID-19-kidney-VWF+PLVAP+EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.62e-04 | 191 | 119 | 5 | 2f00d0b7b2ffce8eb3eb5bbae49a0d425b23c982 | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-21m-Epithelial-basal_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.62e-04 | 191 | 119 | 5 | 8691eba35793e4e90f93d50c2145847ee51289f7 | |
| ToppCell | LV-04._Ventricular_Cardiomyocyte_I|LV / Chamber and Cluster_Paper | 1.65e-04 | 192 | 119 | 5 | ad19e2c1d36a0566c9b12ced10db78f4781c8ea6 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.65e-04 | 192 | 119 | 5 | cc9911e182a289779a2612bc213daae5607689e7 | |
| ToppCell | facs-Lung-nan-3m-Endothelial-Capillary_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.65e-04 | 192 | 119 | 5 | 4bab9754cfd8b9c2d7cc1490e8a29f58c3c26f6c | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Vein|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.65e-04 | 192 | 119 | 5 | 717f3d3bbee4d0f64ba1341ee2b00a407ba1e0f3 | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Myeloid-Monocytic-Nonclassical_Monocyte-Mono_c4-CD14-CD16|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.70e-04 | 193 | 119 | 5 | f492ed02a46f3a45dc6005f9f18ab12a84bfa2a3 | |
| ToppCell | severe-low-quality_cells|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.70e-04 | 193 | 119 | 5 | 9337bc93e3904c7fc7c93c328518bcd6453b1e8c | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW10-Myeloid|GW10 / Sample Type, Dataset, Time_group, and Cell type. | 1.74e-04 | 194 | 119 | 5 | 4f28841c7f37884fc34c6689cd6976c6559d23f1 | |
| ToppCell | LPS_only-Endothelial|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.74e-04 | 194 | 119 | 5 | 58f069efdefa0366033764446b9d6ffd4a17807e | |
| ToppCell | droplet-Lung-30m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_endothelial_cell|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.74e-04 | 194 | 119 | 5 | fc3f81b5bdc544a69c355e482f002643e029a7b0 | |
| ToppCell | 11.5-Distal-Mesenchymal-Pericyte|Distal / Age, Tissue, Lineage and Cell class | 1.74e-04 | 194 | 119 | 5 | 08701590496cf85ff790e54a81493c61177e76ff | |
| ToppCell | LPS_only-Endothelial-Endothelial|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.74e-04 | 194 | 119 | 5 | bfd92ec75facb0ba55c31e5f2e089d983b3d0169 | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW10-Myeloid-Microglia|GW10 / Sample Type, Dataset, Time_group, and Cell type. | 1.74e-04 | 194 | 119 | 5 | 459e836bcdb6742333684ac23d960efa5e99702f | |
| ToppCell | Adult-Immune-T_lymphocyte-D231|Adult / Lineage, Cell type, age group and donor | 1.74e-04 | 194 | 119 | 5 | 5c1dca33f382f37a7deb23e573578343c3b54986 | |
| ToppCell | Control-Epithelial-ATII|Epithelial / Disease state, Lineage and Cell class | 1.74e-04 | 194 | 119 | 5 | a01de094f7bfd099bcbb2f94224690a2efb887b4 | |
| ToppCell | 3'-Child04-06-SmallIntestine-Endothelial-blood_vessel_EC-Mature_venous_EC|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.78e-04 | 195 | 119 | 5 | 527a5a50d6e2cbbbd64d11609e5cde2e33f14797 | |
| ToppCell | Endothelial-A-Donor_07|World / lung cells shred on cell class, cell subclass, sample id | 1.78e-04 | 195 | 119 | 5 | c3a0aa34b672c99cb3a2a4e9218412dbd19da3ca | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.78e-04 | 195 | 119 | 5 | 9ab3c5b0fb12d406408122a535b717bfe184bbcf | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.78e-04 | 195 | 119 | 5 | 21263d138c81f6a0219f2cd93126cfafd35732b2 | |
| ToppCell | ASK452|World / Donor, Lineage and Cell class of Lung cells from Dropseq | 1.78e-04 | 195 | 119 | 5 | 7efd9d3a3f5e7dfe9698a4143ce4a0f9bf3a862c | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.3.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.82e-04 | 196 | 119 | 5 | 7e5addaa844e66f8160e05858c341866a80aed23 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.82e-04 | 196 | 119 | 5 | 676c56b44ac29f7baecb62f49bb8597cc74c0a88 | |
| ToppCell | T_cells-GZMK+_T_cells|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 1.82e-04 | 196 | 119 | 5 | fa5c7fec9e0dcd7e62ff64704bfdf2a3437a43ba | |
| ToppCell | severe-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.86e-04 | 197 | 119 | 5 | 57ebd552f10d6278623b52a3d484d4b91ae1d028 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_pro-infl_II-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.86e-04 | 197 | 119 | 5 | b597c292fc1cb381a4325fed15a32966c38def28 | |
| ToppCell | 5'-Airway_Nasal-Immune_Myeloid-Dendritic-CD1c-positive_myeloid_dendritic_cell-DC2_(CD1c+_dendritic_cell)-DC2_L.1.2.1.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.86e-04 | 197 | 119 | 5 | 515a2d0ee2bd3fc0a5a0c315e2b0c752e6af7406 | |
| ToppCell | 5'-Airway_Nasal-Immune_Myeloid-Dendritic-CD1c-positive_myeloid_dendritic_cell|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.86e-04 | 197 | 119 | 5 | bfa04e5f4156a01df4217b1f59676edb0a7563e1 | |
| ToppCell | COVID-19-kidney-T-cells-1|kidney / Disease (COVID-19 only), tissue and cell type | 1.86e-04 | 197 | 119 | 5 | 9bb7faf4ef63cca4d06c60e6c05a9616fdb6b98e | |
| ToppCell | COVID-19_Mild|World / Disease group, lineage and cell class | 1.86e-04 | 197 | 119 | 5 | 5c33454b10023decd2f5ccda9229b6512659711e | |
| ToppCell | nucseq-Immune-Immune_Myeloid-IM|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.86e-04 | 197 | 119 | 5 | 6f41c8f815851968849428ec92c16745bd01a3fb | |
| ToppCell | Healthy/Control-cDC|World / Disease group and Cell class | 1.86e-04 | 197 | 119 | 5 | 4497d4073f4d3e74de907325fba9eb4af5766bf4 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.86e-04 | 197 | 119 | 5 | bf10727fbe90b71d2ac60a11711e5f0701b3799d | |
| ToppCell | 5'-Airway_Nasal-Immune_Myeloid-Dendritic-CD1c-positive_myeloid_dendritic_cell-DC2_(CD1c+_dendritic_cell)|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.86e-04 | 197 | 119 | 5 | 4fccdc69ab4b966de6465f06677435e6f6e6abcd | |
| ToppCell | nucseq-Immune-Immune_Myeloid-IM-IM|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.86e-04 | 197 | 119 | 5 | 304044ace926943b8eb588f686ecbe5d1689a809 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.91e-04 | 198 | 119 | 5 | c01091ef18e096d792ea2a7a715764a5b215355f | |
| ToppCell | Endothelial-A|World / lung cells shred on cell class, cell subclass, sample id | 1.91e-04 | 198 | 119 | 5 | dd096d4b9f428615f927f7df7cbf5cede0e0e605 | |
| Drug | udenafil | 7.27e-06 | 8 | 117 | 3 | ctd:C419664 | |
| Drug | LDN 193189 | 7.27e-06 | 8 | 117 | 3 | ctd:C554430 | |
| Drug | LY2109761 | 1.55e-05 | 10 | 117 | 3 | ctd:C530108 | |
| Drug | NSC350854 | 2.02e-05 | 108 | 117 | 6 | CID000434448 | |
| Drug | Sp 1 (pharmaceutical) | FOXM1 HIF1A TCF7 PPRC1 SRCAP FOSL1 G3BP1 MDC1 LRCH4 NOS3 SMAD1 SMAD3 | 2.59e-05 | 548 | 117 | 12 | CID000099040 |
| Drug | L-N(Omega)-Nitroarginine-2,4-L-Diaminobutyric Amide | 2.62e-05 | 2 | 117 | 2 | DB01821 | |
| Drug | S-Ethyl-N-Phenyl-Isothiourea | 2.62e-05 | 2 | 117 | 2 | DB03707 | |
| Drug | N-{(3S,4S)-4-[(6-AMINO-4-METHYLPYRIDIN-2-YL)METHYL]PYRROLIDIN-3-YL}-N'-(4-CHLOROBENZYL)ETHANE-1,2-DIAMINE | 2.62e-05 | 2 | 117 | 2 | DB08018 | |
| Drug | N-{(3R,4S)-4-[(6-amino-4-methylpyridin-2-yl)methyl]pyrrolidin-3-yl}-N'-(3-chlorobenzyl)ethane-1,2-diamine | 2.62e-05 | 2 | 117 | 2 | DB08019 | |
| Drug | L-N(Omega)-Nitroarginine-(4r)-Amino-L-Proline Amide | 2.62e-05 | 2 | 117 | 2 | DB02077 | |
| Drug | N-{(4s)-4-Amino-5-[(2-Aminoethyl)Amino]Pentyl}-N'-Nitroguanidine | 2.62e-05 | 2 | 117 | 2 | DB02027 | |
| Drug | Nitroarginine | 2.62e-05 | 2 | 117 | 2 | DB04223 | |
| Drug | galangin | 2.65e-05 | 68 | 117 | 5 | ctd:C037032 | |
| Drug | sauchinone | 3.07e-05 | 35 | 117 | 4 | ctd:C410958 | |
| Drug | Doxorubicin hydrochloride [25316-40-9]; Down 200; 6.8uM; PC3; HT_HG-U133A | 4.71e-05 | 184 | 117 | 7 | 4610_DN | |
| Disease | limb ischemia (biomarker_via_orthology) | 4.58e-05 | 3 | 116 | 2 | DOID:0050852 (biomarker_via_orthology) | |
| Disease | Intestinal Perforation | 4.58e-05 | 3 | 116 | 2 | C0021845 | |
| Disease | Left Ventricle Remodeling | 7.48e-05 | 21 | 116 | 3 | C0600520 | |
| Disease | Ventricular Remodeling | 7.48e-05 | 21 | 116 | 3 | C0600519 | |
| Disease | acute kidney failure (biomarker_via_orthology) | 9.95e-05 | 61 | 116 | 4 | DOID:3021 (biomarker_via_orthology) | |
| Disease | Partial Fetal Alcohol Syndrome | 1.52e-04 | 5 | 116 | 2 | C3661483 | |
| Disease | Alcohol Related Neurodevelopmental Disorder | 1.52e-04 | 5 | 116 | 2 | C0814154 | |
| Disease | Alcohol Related Birth Defect | 2.27e-04 | 6 | 116 | 2 | C3146244 | |
| Disease | Loeys-Dietz Syndrome | 3.18e-04 | 7 | 116 | 2 | C2697932 | |
| Disease | brain ischemia (implicated_via_orthology) | 3.53e-04 | 35 | 116 | 3 | DOID:2316 (implicated_via_orthology) | |
| Disease | pulse pressure measurement | BRPF3 MAP1B TRPM7 CKAP5 FRYL RRAS SRCAP NSD3 MLIP KCNQ5 PITPNM3 NAV1 CLEC16A TCF7L1 SMAD3 | 3.71e-04 | 1392 | 116 | 15 | EFO_0005763 |
| Disease | lung cancer (implicated_via_orthology) | 5.42e-04 | 9 | 116 | 2 | DOID:1324 (implicated_via_orthology) | |
| Disease | bladder neck obstruction (biomarker_via_orthology) | 5.42e-04 | 9 | 116 | 2 | DOID:13948 (biomarker_via_orthology) | |
| Disease | Congenital small ears | 5.66e-04 | 41 | 116 | 3 | C0152423 | |
| Disease | Secondary Biliary Cholangitis | 6.08e-04 | 42 | 116 | 3 | C0238065 | |
| Disease | Cleft palate, isolated | 6.08e-04 | 42 | 116 | 3 | C1837218 | |
| Disease | Biliary cirrhosis | 6.08e-04 | 42 | 116 | 3 | C0023892 | |
| Disease | Biliary Cirrhosis, Primary, 1 | 6.08e-04 | 42 | 116 | 3 | C4551595 | |
| Disease | Diabetes, Autoimmune | 6.97e-04 | 44 | 116 | 3 | C0205734 | |
| Disease | Brittle diabetes | 6.97e-04 | 44 | 116 | 3 | C0342302 | |
| Disease | Diabetes Mellitus, Sudden-Onset | 6.97e-04 | 44 | 116 | 3 | C4554117 | |
| Disease | Diabetes Mellitus, Ketosis-Prone | 6.97e-04 | 44 | 116 | 3 | C3837958 | |
| Disease | Diabetes Mellitus, Insulin-Dependent | 7.45e-04 | 45 | 116 | 3 | C0011854 | |
| Disease | Gastric Adenocarcinoma | 7.45e-04 | 45 | 116 | 3 | C0278701 | |
| Disease | diabetic retinopathy (biomarker_via_orthology) | 7.45e-04 | 45 | 116 | 3 | DOID:8947 (biomarker_via_orthology) | |
| Disease | N-acetylphenylalanine measurement | 8.23e-04 | 11 | 116 | 2 | EFO_0800019 | |
| Disease | Cleft palate, tobacco smoke exposure measurement, cleft lip, parental genotype effect measurement | 8.23e-04 | 11 | 116 | 2 | EFO_0003959, EFO_0005939, EFO_0009115, HP_0000175 | |
| Disease | Primary biliary cirrhosis | 8.46e-04 | 47 | 116 | 3 | C0008312 | |
| Disease | congestive heart failure (biomarker_via_orthology) | 8.57e-04 | 107 | 116 | 4 | DOID:6000 (biomarker_via_orthology) | |
| Disease | cholestasis (biomarker_via_orthology) | 9.56e-04 | 49 | 116 | 3 | DOID:13580 (biomarker_via_orthology) | |
| Disease | hepatocellular carcinoma (implicated_via_orthology) | 9.56e-04 | 49 | 116 | 3 | DOID:684 (implicated_via_orthology) | |
| Disease | developmental disorder of mental health (implicated_via_orthology) | 9.56e-04 | 49 | 116 | 3 | DOID:0060037 (implicated_via_orthology) | |
| Disease | serum gamma-glutamyl transferase measurement | TRPM7 JMJD1C PDHX NCOR2 MLIP SALL1 TJP1 PCIF1 NR1I3 NOTCH2 ZNF292 | 9.71e-04 | 914 | 116 | 11 | EFO_0004532 |
| Disease | cardiomyopathy (biomarker_via_orthology) | 1.16e-03 | 13 | 116 | 2 | DOID:0050700 (biomarker_via_orthology) | |
| Disease | liver cirrhosis (implicated_via_orthology) | 1.16e-03 | 13 | 116 | 2 | DOID:5082 (implicated_via_orthology) | |
| Disease | juvenile polyposis syndrome (implicated_via_orthology) | 1.16e-03 | 13 | 116 | 2 | DOID:0050787 (implicated_via_orthology) | |
| Disease | Fetal Alcohol Spectrum Disorders | 1.16e-03 | 13 | 116 | 2 | C2985290 | |
| Disease | Diffuse Large B-Cell Lymphoma | 1.34e-03 | 55 | 116 | 3 | C0079744 | |
| Disease | diastolic blood pressure, systolic blood pressure | 1.34e-03 | 670 | 116 | 9 | EFO_0006335, EFO_0006336 | |
| Disease | hepatic encephalopathy (biomarker_via_orthology) | 1.56e-03 | 15 | 116 | 2 | DOID:13413 (biomarker_via_orthology) | |
| Disease | Eczema, allergic rhinitis | 1.63e-03 | 215 | 116 | 5 | EFO_0005854, HP_0000964 | |
| Disease | Malignant neoplasm of skin | 1.64e-03 | 59 | 116 | 3 | C0007114 | |
| Disease | Skin Neoplasms | 1.64e-03 | 59 | 116 | 3 | C0037286 | |
| Disease | diabetic retinopathy (implicated_via_orthology) | 1.77e-03 | 16 | 116 | 2 | DOID:8947 (implicated_via_orthology) | |
| Disease | Colorectal Carcinoma | 1.85e-03 | 702 | 116 | 9 | C0009402 | |
| Disease | rhinitis | 2.00e-03 | 17 | 116 | 2 | EFO_0008521 | |
| Disease | pre-eclampsia (biomarker_via_orthology) | 2.00e-03 | 17 | 116 | 2 | DOID:10591 (biomarker_via_orthology) | |
| Disease | Fetal Alcohol Syndrome | 2.00e-03 | 17 | 116 | 2 | C0015923 | |
| Disease | frontal pole volume measurement | 2.25e-03 | 18 | 116 | 2 | EFO_0010304 | |
| Disease | breast carcinoma (is_marker_for) | 2.26e-03 | 66 | 116 | 3 | DOID:3459 (is_marker_for) | |
| Disease | Grand Mal Status Epilepticus | 2.36e-03 | 67 | 116 | 3 | C0311335 | |
| Disease | Status Epilepticus, Subclinical | 2.36e-03 | 67 | 116 | 3 | C0751522 | |
| Disease | Simple Partial Status Epilepticus | 2.36e-03 | 67 | 116 | 3 | C0751524 | |
| Disease | Non-Convulsive Status Epilepticus | 2.36e-03 | 67 | 116 | 3 | C0751523 | |
| Disease | Petit mal status | 2.36e-03 | 67 | 116 | 3 | C0270823 | |
| Disease | Complex Partial Status Epilepticus | 2.36e-03 | 67 | 116 | 3 | C0393734 | |
| Disease | Status Epilepticus | 2.46e-03 | 68 | 116 | 3 | C0038220 | |
| Disease | portal hypertension (implicated_via_orthology) | 2.51e-03 | 19 | 116 | 2 | DOID:10762 (implicated_via_orthology) | |
| Disease | polycystic kidney disease (biomarker_via_orthology) | 2.51e-03 | 19 | 116 | 2 | DOID:0080322 (biomarker_via_orthology) | |
| Disease | asthma, age at onset | 2.68e-03 | 70 | 116 | 3 | EFO_0004847, MONDO_0004979 | |
| Disease | eosinophil percentage of leukocytes | 2.78e-03 | 746 | 116 | 9 | EFO_0007991 | |
| Disease | Metabolic Syndrome X | 3.06e-03 | 21 | 116 | 2 | C0524620 | |
| Disease | neuroimaging measurement | ANK3 MAP1B KSR2 FRYL JMJD1C EFTUD2 ZNF469 G3BP1 DENND4B LRCH4 ARHGAP27 | 3.30e-03 | 1069 | 116 | 11 | EFO_0004346 |
| Disease | cervical squamous cell carcinoma (is_marker_for) | 3.36e-03 | 22 | 116 | 2 | DOID:3744 (is_marker_for) | |
| Disease | impotence (biomarker_via_orthology) | 3.36e-03 | 22 | 116 | 2 | DOID:1875 (biomarker_via_orthology) | |
| Disease | hemoglobin measurement, mean corpuscular hemoglobin | 3.36e-03 | 22 | 116 | 2 | EFO_0004509, EFO_0004527 | |
| Disease | Glioblastoma | 3.77e-03 | 79 | 116 | 3 | C0017636 | |
| Disease | pulmonary hypertension (biomarker_via_orthology) | 3.90e-03 | 80 | 116 | 3 | DOID:6432 (biomarker_via_orthology) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| TKTEEQGIPRPLHPP | 1106 | Q9UKV3 | |
| IEKPSPNIPIELIPH | 841 | Q5SW79 | |
| TPQVDELDILPIHPP | 446 | Q9BSF8 | |
| TPEIPSGLPLHIVLV | 61 | A8MXV6 | |
| TPRPKIISPVSGPEH | 211 | O42043 | |
| TPRPKIISPVSGPEH | 321 | Q9UKH3 | |
| VPEKVSEPLPGPSHE | 301 | Q5CZ79 | |
| PLLPVEIPDIHPLLA | 386 | A6NCI8 | |
| HISPIKPTEAVLPSP | 156 | Q12959 | |
| DSHLPEEALKVPPVP | 1681 | Q8TCU4 | |
| HNGVPIPVPPLDVLK | 1106 | Q9ULD4 | |
| KPSPLTEPLILHLTP | 671 | Q8IV53 | |
| EKIPAKELPPISPEH | 506 | Q8IYB7 | |
| LHPPPVSKSEIKSIP | 356 | Q9Y2E6 | |
| IPIPKIPQIHPEEVP | 1251 | Q96MT7 | |
| QDVTVPPKPVSLHPL | 371 | Q5VWP3 | |
| VPIHVPPTTENKPKV | 196 | P62491 | |
| TAELVIPELPLAHPP | 221 | Q9NZQ7 | |
| SVPFIHVPSPAVPKL | 581 | O75427 | |
| QPLPTLAPVLPLVTH | 146 | Q14994 | |
| IEDVPPPTKKLTPEL | 851 | Q6ZW49 | |
| PPKTQVSSLHLEPPE | 226 | Q5HY64 | |
| PPKILVSSLHQAPPE | 526 | Q5HY64 | |
| PELPKPRVSSLHLEP | 776 | Q5HY64 | |
| EPKTPSVPSVPHELP | 1016 | Q9C0D6 | |
| AAIPPIQVTKVHEPP | 971 | Q9Y618 | |
| GKHITTPREPLPPIV | 2291 | Q04721 | |
| KEILVPGPRHPETSP | 216 | A5PL33 | |
| SHLPTEVIEKPPAVP | 1346 | P46821 | |
| VKTPEPVVPTAPEPH | 1606 | Q14676 | |
| PLPVKDQDHTVPEPL | 501 | Q96JE9 | |
| DEVSPTPPITVTHKP | 411 | Q16288 | |
| EILPPPAEKSPSVEL | 366 | Q5H9T9 | |
| TIITPPTPIIPDDHP | 336 | P50440 | |
| PSPVPHELVITIELP | 276 | Q9NVR5 | |
| PIPHPSNIEIPLDSK | 226 | Q16665 | |
| RTSVLPEHKDPPPEV | 126 | O15327 | |
| PPPLIKHQPESEGLV | 1146 | Q15652 | |
| TTLQIPPPLPAIKHL | 746 | Q9NR82 | |
| VPETPTRAPQVILHP | 581 | Q6VAB6 | |
| TTPIKPPPAHVEKTV | 596 | Q5CZC0 | |
| LHPVPQPPTLAEAVK | 726 | Q5VYM1 | |
| APTKKIIDPLPPIDH | 191 | Q86XP3 | |
| EKKSIIPLPHPVRPE | 161 | P61599 | |
| KLTEVPVEPVLTVHP | 536 | Q9H307 | |
| PSPEPQISIPVKKEH | 161 | O00330 | |
| DTPPKRHLITPVPDS | 656 | Q9H5P4 | |
| SPISVVPEKHLTLPP | 96 | A6H8Z2 | |
| KQIPVHPVPDPLVHE | 136 | O94915 | |
| PEPPKTLVSSVHPEP | 261 | Q8NA70 | |
| APPVLGKHTEPPVTS | 1376 | P35658 | |
| VGPELLPPPKHTFEV | 1541 | Q07864 | |
| EHLTQSIVPPPKPER | 1971 | A7KAX9 | |
| IPPELVLEVPIRHPK | 541 | P29475 | |
| PPELVLEVPLEHPTL | 306 | P29474 | |
| LPPELLVQVLSHVPP | 21 | Q96EF6 | |
| EVPLPHKTPIQPGEE | 166 | Q9ULV1 | |
| PVLIPEPKIRAVSPH | 1516 | Q14008 | |
| EPSRNPKIVVPIPVH | 316 | P52951 | |
| PSEVLPPHPEVELLR | 191 | Q9H4Z3 | |
| RLKTPTQHSPVPPEE | 131 | Q9Y603 | |
| TPRPKIISPVSGPEH | 211 | P61566 | |
| PVTGIPPHVVKVPAS | 266 | Q13283 | |
| RPIVPKVLPPQATSH | 936 | Q96RY5 | |
| PEQPEKPLDLAHIVP | 321 | O60941 | |
| KPLDLAHIVPPRPLT | 326 | O60941 | |
| LAKDTPPAHPITRVP | 416 | Q7Z591 | |
| PLFHEVPIPPVITET | 2151 | Q12955 | |
| PSLHLKLLSVVPVPE | 86 | Q9GZN8 | |
| TPRPKIISPVSGPEH | 321 | P61565 | |
| PLSPHNITPEPVSKL | 111 | Q6VMQ6 | |
| VHPEQEKPEPTPLVE | 656 | O75064 | |
| PHLARPIKVESPPLE | 471 | Q08050 | |
| IKQSDSVEPIPPRHP | 936 | Q9ULL0 | |
| KHLDVPDIIITPPTP | 31 | Q96GX8 | |
| LVPEHDAPQKLLPIP | 651 | Q92622 | |
| LIPFIKTEEPAPIPI | 566 | Q9NSC2 | |
| EPTKVEVKPVPASPH | 1051 | Q5VV67 | |
| HLPEKIRPEIPIPEE | 726 | Q5VW36 | |
| PGPVLEPEALHTPTL | 206 | P15407 | |
| LHADPEPSVIPDVKP | 36 | Q5THK1 | |
| HPTATKLAELPPTPL | 771 | Q8NEY1 | |
| PPALRKPPISVSQHE | 266 | Q6P4E1 | |
| PLIEPHVPLRPANTI | 181 | Q8WZA2 | |
| LPQVPVPAPRSIHKS | 441 | Q6ZUM4 | |
| KPNPPVLHIIEPHEV | 1371 | Q149N8 | |
| LDTHPLPLVEVVVPT | 246 | Q86YJ6 | |
| VPISAPNPITILPVH | 2466 | Q6ZRS2 | |
| EAHPTLIIPPLPEKF | 86 | Q9UNH6 | |
| VESPVLPPVLVPRHN | 131 | Q99717 | |
| ESPVLPPVLVPRHSE | 131 | Q15797 | |
| HGVPIPVPPLEVLKL | 1116 | P55201 | |
| PEIPTTVLNIPHPSV | 231 | P25440 | |
| DHPKPVTVKPVTTEP | 86 | Q8WWF1 | |
| AKRHLAELSVPPVPP | 146 | Q96P48 | |
| PELPKPHLPDQLVIV | 941 | Q2KHT3 | |
| PPPKPVIVDKHRPVE | 56 | P49406 | |
| EKPLRHPPLPEAAVT | 1101 | Q9NRJ4 | |
| PETPIIVVKQGHEPP | 691 | P09327 | |
| PATLHLPPEIVPATL | 91 | Q9NQ39 | |
| PRIVKTHLPPELLPA | 101 | P49888 | |
| SQPTHLIPPLPEKFV | 146 | Q5VWJ9 | |
| PHPAIVSPIVKQEPA | 306 | Q9HCS4 | |
| ETPVLPPVLVPRHTE | 171 | Q15796 | |
| ETPVLPPVLVPRHTE | 131 | P84022 | |
| PIPIPIPIPHVSDSK | 536 | A7XYQ1 | |
| QLPPTVPVKKIPHDL | 496 | Q5VUG0 | |
| HSTPPEKVLPPEAQL | 831 | O60281 | |
| VEEVAPAKPPRHLTP | 206 | Q5JSH3 | |
| IKAHPLLDPAVPPVT | 396 | Q9H3T2 | |
| LLDPAVPPVTHQPLL | 401 | Q9H3T2 | |
| IPHPAIVPPSGKQEL | 231 | P36402 | |
| IPNTRPHEILEKPSP | 116 | Q9BZ95 | |
| PLLEPKFHLVPPVSV | 446 | Q9BZ71 | |
| RIDHIPDLPLPKPLI | 531 | O14512 | |
| PETLERPVDPVTHPI | 3496 | Q96JG9 | |
| AAVPPLIPSSQHKPE | 1221 | Q07157 | |
| DATPLVKEPHPLPLV | 6 | Q8WVZ1 | |
| SHIKSPPIPEDPEVE | 1161 | Q502W6 | |
| IVIRPLEPQPAPHLA | 916 | Q15029 | |
| PGDPPPSETHKLVVV | 21 | P10301 | |
| PVLPPPLIILSHIVS | 1126 | Q96QT4 | |
| LPDISPPIVIPDDSK | 626 | Q92995 | |
| HDPVKPVTTSPLPAE | 861 | O95405 | |
| PFPKPPLISHLEREV | 106 | Q5JNZ3 | |
| TIPTEKLTALRPPHP | 991 | Q9Y493 | |
| PEESHLSPELEKPPL | 846 | O14686 | |
| KIQKPPLPPTTERHE | 281 | Q13094 | |
| LPPVTHLDLTPSPDV | 296 | Q99538 |